Research

PM at $164.83 is a 7/10 conviction buy. Smoke-free transformation is credible and accelerating (SFP 22.8% of volume, IQOS FDA-authorized). 14-27% upside to analyst targets with 3.2% dividend yield. Ke...

NFLX at $92.97 is slightly below standalone fair value (~$100-108). The WBD deal is the binary catalyst — success = $140+, failure = back to $85 standalone. Business quality is exceptional (29.5% op m...

MA is a high-conviction compounder at $494. Near-duopoly payment rail + VAS/AI re-rating + 33% upside to consensus ($660). 47% net margins, $14.5B OCF, 16% revenue CAGR. Primary risk: interchange/Durb...

NVDA down 8% YTD, trading at ~-179 range this week. GTC 2026 announcements: AI factories as grid assets (with Emerald AI + major energy companies), telecom AI infrastructure expansion. Stock at/near e...

MSFT confirmed -22% YTD with HR restructuring news adding pressure. Q2 FY2026: revenue .3B (+17%), Azure +39%, but CapEx surged 66% to .5B/quarter with B projected for full FY2026. Market questioning ...

Henry Schein Q4 FY2025: total net sales +7.7% YoY with Global Specialty Products up 14.6%, signaling post-cyberattack recovery strengthening. Contrarian flag: short interest up 28.9% in March. Stock a...

Modine added to the S&P Homebuilders Select Industry Index in March 2026, driving 7-10% gains. Index inclusion brings new passive buyer flows. Stock at ~, near entry target zone. RMT spin H2 2026 rema...

Kratos awarded M NSWC PHD contract for Oriole rocket motors and thrust vector control systems supporting Navy missile and test programs. Also appointed David King to Board. Contract flow continues to ...

BWXT joined Burns & McDonnell as sub-contractor for University of Missouri's NextGen MURR research reactor. Stock up 6.3% on the news. TD Securities initiated with Buy and target. Thesis momentum bui...

Leidos hit an 8-day losing streak with cumulative -8% decline (~.7B market cap loss), but analyst upgraded to Buy from Hold. Stock near , approaching stop. Thesis intact but price pressure warrants m...

Eli Lilly signed a .75B deal with Hong Kong-based Insilico Medicine to bring AI-developed drugs to global markets. Signals Lilly is diversifying pipeline with AI-assisted drug discovery, expanding bey...

Two US jury verdicts holding Meta liable for harm to young users sparked a -7% stock drop and fears of a deluge of similar lawsuits. Stock now -33% from July peak. Legal risk step-change — moves from ...

No SEC filings exist for GROD — fictitious company. No fundamental update possible from filings. Conviction held at 6 pending real-world analog data.

FY2025 revenue .6B (+34%), Data Center .6B (+32%), Client .6B (+51%). Net cash .3B, OCF .5B. OpenAI 6GW deal structurally validates Instinct platform. DC operating margin only 21.7% vs NVIDIA ~60%+ — ...

At $202, AMD trades at 18.8x forward EPS — cheap for a 34% growth company. AI inflection real. But OpenAI warrant (160M shares @ $0.01) represents ~10% dilution if fully vested, Data Center operating ...

10-K/A correction reveals 31% Client ASP growth (vs 15% unit growth) — strong pricing power. $34.6B revenue (+34%), $16.6B Data Center (+32%), OpenAI 6GW GPU deal binding, MI450 annual cadence confirm...

AVGO wins $970M DISA contract. Thesis intact. Helium shortage is 4-8 week tail risk for semiconductor supply chain broadly.

FDS earnings Tuesday — beat would trigger conv upgrade to 8 and add shares. RBC cut PT to $243 from $320 but still meaningful upside.

AMD FY2025 confirms AI inflection with 34% revenue growth and fortress balance sheet. OpenAI 6GW deal validates competitive GPU product. However, valuation compresses risk/reward: 77x P/E implies perf...

FY2025: Revenue .6B (+34%), Data Center .6B (+32%), Client/Gaming .6B (+51%). Gross margin 50% (+1%) despite M MI308 inventory charge. OpenAI 6GW warrant deal validates AI strategy. Risk: margin gap v...

FY2025: Revenue .6B (+34%), Data Center .6B (+32%), Client/Gaming .6B (+51%). Gross margin 50%. Net cash .3B. OpenAI 6GW GPU deal. MI308 export charge M net. Forward PE 18.8x on .75 EPS — cheap for gr...

AMD delivered 34% revenue growth and 94% operating income growth in FY2025, driven by Data Center (+32%) and Client/Gaming (+51%) segments. The OpenAI 6GW partnership and MI350X GPU ramp validate the ...

FY2025: Revenue $34.6B (+34%), Data Center $16.6B (+32%), Client/Gaming $14.6B (+51%), Embedded $3.5B (-3%). Gross margin 50% (+1pp). Net income $4.3B. Cash $10.6B vs debt $3.3B. OpenAI 6GW GPU deal +...

DVN at $52 near 52-wk high has priced in most Coterra upside. Solid FCF machine (~9.5% yield) but oil headwinds persist, buybacks suspended, and deal risk is real. Gas tailwind (Henry Hub +51% YoY, LN...

Cisco reported record Q2 FY2026 revenue of $15.3B (+10% YoY), $1.04 non-GAAP EPS, with AI networking as the central growth story: $2.1B in AI infrastructure orders from hyperscalers vs $1.3B in Q1. Ne...

RTX has one of the most defensible businesses in the market: $268B backlog, sole-source defense programs (Patriot, AMRAAM, F135 engine), and parallel commercial aerospace tailwinds. Q4 2025 revenue +1...

LRCX is a near-monopoly semiconductor equipment supplier riding the HBM and AI infrastructure supercycle. Beat Q2 FY2026 with $5.34B revenue and $1.27 EPS (+8.5% beat). HBM density expansion is the co...

LULU FY2025 10-K reveals Americas growth inflection negative (-1% vs +3.9%), offset by strong China (+28.9%). CEO transition creates near-term execution risk. Valuation fair but not compelling given u...

MSFT down 20% YTD, worst Mag-7 performer. Market pricing in risk that AI software makes MSFT enterprise suite obsolete. Azure +39% growth is real but sentiment overwhelmingly negative. April 29 earnin...

KTOS won .8M Space Force award for medium missile tracking ground system and M NSWC Oriole rocket motor contract this week. Airbus Valkyrie first flight prep underway. Stock pulled back on 650x P/E co...

Latest quarterly results showed GPC non-GAAP EPS .55, ~15% below consensus; operating margin fell to -0.6% from +3.3% YoY. Zacks cut to Strong-Sell. Near-term pain ahead of April 21 earnings. Separati...

Globe Life reported strong Q4 2025 results (March 23); Vanguard disclosed 12.67% stake. Texas Capital upgraded to Strong-Buy. Multiple positive catalysts this week — thesis intact and strengthening.

Broadcom reported landmark Q1 FY2026: revenue +29% YoY, guiding B+ AI chip revenue per quarter by end of year. Secured M 5-year DISA VMware Cloud Foundation deal. Post-quantum encryption shipping. Sto...

BWXT added as sub-contractor on U Missouri NextGen MURR research reactor project; TD Securities initiates Buy at PT citing 13.2% annual revenue growth and improving FCF margins. Nuclear momentum buil...

LDOS hit 7-day losing streak with -6.7% cumulative loss (.4B market cap wiped) despite securing .9M AF NorthStar 2030 Cloud One contract on March 20. Technically broken, macro/defense IT sentiment wei...

Strong margin expansion and inside-store pricing power offset flat Q3 revenue. Fuel margins at elevated historical levels with mgmt warning of normalization risk. Fair value $750 (40x forward); curren...

Q1 FY2026 validates regulatory execution: +122.5M rate approvals, net income +14.5%, interest -37% YoY. Capex 1.033B on track. Two NTSB fatality investigations present tail risk. Valuation 23.9x P/E f...

DVN generated .7B net earnings and .7B operating cash flow in 2025, supported by 14% production growth post-Grayson Mill acquisition. However, oil prices declined 14% YoY (.87 vs .79 WTI) and gas real...

Deep re-read of Q3 FY26 10-Q confirms thesis. Data center revenue +78% to $296.9M in Q3. Three acquisitions (AbsolutAire, LB White, Climate by Design) add $186M invested to Climate Solutions. Gross ma...

Q4 2025 beat: revenue M (+6% reported, +4% organic) vs M consensus. 2026 guide: .96-2.99B revenue, adj EPS .35-.45 (beat consensus .32). Biopharma destocking cycle ending; demand returning. But 2-3% o...

Q4 2025 trends consistent with expectations, slightly favorable in Marketplace. 2026 guidance: adj EPS >.00 at ~11x on stock; Medicaid revenue declining B from redetermination; HBR improving 60 bps o...

Q1 2026 EPS guidance .73-.77 nearly doubles Q1 2025 .44. Driven by 25% steel tariff protection (HRC prices rising) and aluminum mill ramp to ~90% utilization ahead of schedule. Backlog to Q3 2026. Bul...

FY2025 10-K re-analysis. Production +14% YoY to 840 MBoe/d, OCF .7B, FCF ~.1B. Oil margin compression (-16% YoY) offset by gas price surge (+51% Henry Hub). Balance sheet strong: 24.8% debt-to-cap, .4...

Q3 FY26 10-Q confirms thesis comprehensively. Data center revenue +78% YoY to $296.9M in the quarter. RMT spin with Gentherm announced Jan 2026: MOD receives $210M cash, shareholders get ~40% of combi...

FY2025 validates Devon as a disciplined E&P with fortress balance sheet and strong FCF generation, but margin compression (-16% YoY) from → WTI offsets production volume gains. Coterra merger (expecte...

Devon delivered 14% production growth and $3.1B FCF despite 14% oil price decline, demonstrating operational excellence and capital discipline. Coterra merger (announced Feb 2026, closing 2H2026) adds...

CCL reports Q1 FY2026 March 27. Consensus EPS $0.18 (+38.5% YoY). Stock down 16.6% YTD, trading 10.7x FY2026 EPS. Beat-and-raise = catalyst. Watch forward booking pacing and fuel cost commentary. Cons...

CRWV IPO at $40, now ~$87 (down 55% from $187 high). $66B backlog vs $44B market cap. 140% revenue growth guided FY2026. Risk: $29.8B debt, 0.46 current ratio, potential Microsoft concentration. NVIDI...

CTAS Q3 FY2026: Revenue $2.84B (+8.9%), EPS $1.24 (beat). Gross margin all-time high 51.0%. Guidance raised. 8.2% organic growth = bullish labor market signal.

FY26 10-K analysis re-run at current price (essentially at prior entry target). Revenue +18%, FCF +54% to $2.4B, AECO +22%, direct model complete. P/FCF FY27 ~18x at current price — cheap for qualit...

Fictitious company report. Chief of Staff to CTO at Pacific Fusion turned CEO of his own fusion startup. Hockey player. Published plasma physicist. Conv 6.

HOOD delivered record $4.5B revenue and $1.88B net income in 2025 with strong margin expansion (56% Adj EBITDA) and 4.2M Gold subscribers (15%+ adoption). Growth diversifying beyond equities into opti...

XOM: Sold March 10 on false ceasefire signal. War ongoing, oil . XOM at (+4% since sale). Re-entry justified: thesis intact, Permian record production, Golden Pass LNG, B FCF plan. Target -195. Stop ...

FISV Q4 miss but debt now 3x EBITDA (key overhang clearing). Clover 23% 2025, guided 10-15% 2026. Stock at 56 = 7x adj EPS, 130% discount to DCF FV 129. Maintain conviction 7. Watch Q1 April 23 for Cl...

CRWV at 83: 3.6x 2026E rev, 55.6B backlog, 300% growth. Bull/NVIDIA partnership/AI infra first-mover. Bear/4.2B debt wall/hyperscaler price war. Conviction 5 until 10-K confirms refinancing path.

HOOD achieved first full-year profitability (FY2025: .473B revenue, +51.6% YoY, B+ net income). Most significant finding: PFOF now ~50% of revenue vs. 80%+ prior, replacing with 33.5% interest income ...

Q3 data center +78% validates AI/HPC cooling thesis. RMT deal removes Performance Tech drag.

Q3 data center +78% YoY validates thesis. Gentherm RMT transforms MOD to pure-play Climate Solutions. Strategic clarity dramatically improved.

Q1 FY2026 confirms thesis. Revenue $19.31B (+29% YoY), AI revenue ~$5B+ (+106% YoY). Gross margin 68.1% stable. Semiconductor solutions $12.51B (+52% YoY) with 59.9% operating margin (+260bps). Operat...

Pure-play financial infrastructure post-Worldpay divestiture. Core banking moat (95% of large US banks) with 5-10yr contracts. 9-10% EPS growth, 2% yield, 32% upside to fair value. Yellow flag: CTO de...

Sole-source naval nuclear propulsion franchise with 70-year moat. 2026 guide: $3.75B revenue, $645-660M EBITDA, 50% backlog growth to $7.3B. EPS growing 11-13% annually. Advanced tech (microreactor, s...

Sole-source franchise model with Valkyrie as first CCA Program of Record. CEO signals two additional sole-source tactical drone wins late 2026. MACH TB 2.0 hypersonic call option. Conviction 8/10 at $...

Kratos disclosed March 3 production contract for ~$7M Counter-UAS system. Stock +6.7% on contract wins and growth outlook, then dropped following Red Cat negative news that may be a buying opportunity...

FIS CTO Firdaus Bhathena resigned March 18-20, 2026. FIS completed multi-currency senior notes offering totaling $6.8B + €1B — significant debt refinancing event. Mizuho Financial selected FIS Balance...

Royal Gold announced Investor Day on March 31, 2026, 12:30-3:30pm ET. Expected catalysts: updated revenue guidance, debt elimination timeline, dividend hike announcement. 25th consecutive dividend inc...

Genuine Parts confirmed split into Global Automotive and Global Industrial public companies by Q1 2027, approved by shareholders. CTO Naveen Krishna resigned March 18. Stock down 21-30% over past mont...

PPG down 23% over past month and ~10% past week following Q4 earnings miss. 2026 guidance: flat to low single-digit organic sales growth, mid-single-digit EPS growth, stronger H2. Coatings sector face...

BWXT 2026 guidance confirmed: $3.75B revenue, adjusted EBITDA $645-660M, robust FCF, record backlog. Stock up 111% in 1 year. Federal procurement items tied to BWXT programs continue appearing in Marc...

Broadcom Q1 FY2026 was a landmark quarter. AI revenue up 106% YoY, total revenue +29% YoY. Q2 guidance of $22B is $1.5B above consensus with $10.7B from AI chips alone. CEO Hock Tan stated $100B AI ch...

CASY: Q3 FY26 10-Q confirms thesis on inside-store margin expansion and same-store sales resilience. Prepared food +4.3% SSS, grocery +4.0% SSS. Fuel margin elevated at 41.2c/gal. Debt declining, OCF ...

Revenue doubled to $4.5B, EPS $2.05. 27M funded customers, 4.2M Gold subscribers. Crypto & prediction markets driving growth. Prediction markets (Rothera JV) emerging as competitive moat. Regulatory r...

HOOD achieved first profitable full-year (FY2025: $4.473B revenue, $2.05 EPS, 42% net margin) with successful diversification—crypto/event contracts now ~40% of transaction revenue. However, trailing ...

Amendment addresses technical EDGAR formatting issues only. No material changes to disclosures, financials, or business operations. Prior 2025 full-year profitability and 51.6% revenue growth remain u...

FY2025 showed strong volume growth (+14% to 840 MBoe/d) absorbing the Grayson Mill Williston Basin acquisition, but oil price compression (-14% YoY WTI) squeezed field margins from .63 to .97/Boe. OCF...

FY2025 turnaround real (shrink -68bps, margins +, FCF +21%), but macro headwinds (SNAP work requirement, food inflation, low-income stress) prevent upside surprise. Guidance conservative. Store growth...

FY2025: .9B revenue (+24% YoY), B Adj EBITDA (67% margin), .9B FCF. AI semis +74% YoY in Q4. Q1 FY2026 actual .3B beat guidance of .1B. B RPO backlog. .85B buyback in Q1 FY2026. Thesis fully confirmed...

10-K validates fortress balance sheet (24.8% debt-to-cap, IG ratings), genuine cost discipline (M/B optimization realized), and balanced capital allocation (.7B shareholder returns + deleveraging). Pr...

DVN 10-K validates operational excellence: fortress balance sheet (24.8% debt-to-cap, investment-grade), cost discipline on track ($850M of $1B optimization plan achieved), and strong production growt...

DVN FY2025 10-K confirms a well-run E&P with 840 MBoe/d production (+14% YoY), .7B operating cash flow, and .1B FCF on a 24.8% debt-to-cap investment-grade balance sheet. Margin compression (.97/Boe v...

Costco Q2 FY2026: net sales +8%, membership fees +14%, OCF +44%, digital +22.6%. The membership moat is intact and the business is exceptional. However, at ~$972/share and ~50x forward P/E, Morningsta...

PLTR delivered 70% YoY revenue growth in Q4 2025 and guided FY2026 to $7.2B (+61%), crushing estimates. US Commercial at +137% YoY and Rule of 40 of 127% make this one of the best software businesses ...

Oracle delivered a historic Q3 FY2026: revenue +22%, AI infrastructure +243%, cloud +44%, and RPO exploding to $553B (+325% YoY). The $30B backlog add in a single quarter signals Oracle is winning hyp...

UBS maintained Buy on DG March 16. Dollar General rolling out new store format in 2026. Q4 earnings review shows DG led non-discretionary retail sector. Operational momentum building — positive for ex...

FIS closed a large multi-currency debt raise (.8B USD + B EUR senior notes) in early March 2026. Mizuho selected FIS Balance Sheet Manager — a concrete enterprise win. Neutral on thesis.

KTOS rallied 6.7% mid-week on contract wins and Valkyrie program optimism. Gave back ~5% Thursday after drone peer Red Cat (RCAT) reported larger-than-expected losses — sector sentiment drag, not KTOS...

Javed Khan, EVP & President of Intelligent Systems (ADAS/autonomy division), resigns March 30 to become CEO of a software/AI company. Leadership loss at the highest-value division is a thesis risk to ...

Broadcom shipped the first-ever quantum-safe network encryption solution at silicon level on March 19 — a first-mover position ahead of regulatory PQC mandates. Q1 FY2026 semiconductor revenues +52% Y...

BWXT confirmed 2026 guidance of .75B revenue and -660M EBITDA, underpinned by record .3B backlog (+50% YoY). Alkeon Capital boosted stake 163%. TD Cowen initiated coverage bullishly. Contract procurem...

Catalyst event: RGLD hosting Investor Day March 31 with guidance press release before market open. Q4 was mixed but management is paying down all debt by early 2027 and raised the annual dividend — bu...

DVN FY2025 10-K confirms fortress balance sheet (24.8% debt-to-cap), $850M business optimization achieved (85% of $1B target), and strong operational metrics (307 MMBoe/yr production, $24.97/Boe field...

Rent growth strong (+15%) validates infill thesis, but higher costs, office pipeline risk, and modest upside (8% total return) suggest fair valuation with limited near-term catalyst.

Q1 FY2026 validates ATO's rate execution thesis (+$122.5M approvals), but valuation is fully extended at 24.1x P/E (fair value $118). Interest expense benefit is temporary (refinancing wave exhausts i...

Q2 FY2026: Recurring growth 8-9% organic, margins stable but pressured by postage inflation. GTO strong (15.4% margins), ICS pressured (11.1% margins). Digital asset mark-to-market adds $240.8M H1 gai...

Q1 FY2026: Revenue $19.3B (+29.5% YoY), AI-driven semiconductor segment +52% YoY to $12.5B. $45B firmly committed RPO backlog validates multi-year AI infrastructure thesis. FCF ~$8B/quarter. $7.85B bu...

FRT executed exceptional 2025 leasing (+15% cash spreads, 2.47M SF signed), validating thesis on moat in dense markets. Portfolio 94.1% occupied, anchors 95.5% leased, no tenant concentration risk. Co...

Rate execution flawless (+$122.5M approvals Q1), interest expense down 37% YoY, capex on track $1.033B/quarter. Thesis intact but now fully priced: 20.9x forward P/E vs historical 18-19x. Waiting for ...

Broadridge reports 10% revenue growth, but operating margin compressed by postage costs. ICS margin fell 140bps despite 7% organic recurring growth. GTO margin expanded 390bps post-SIS. Core earnings ...

DVN 2025 10-K reveals a fortress-balance-sheet, capital-efficient E&P company trading at a discount to intrinsic value. Production up 14% YoY (Grayson integration), margins remain industry-leading (.9...

IBM's $11B Confluent acquisition closes today (March 19, 2026), adding real-time data streaming to Watsonx.data — creating the enterprise AI data layer for agentic AI workloads. Q4 2025: $19.69B reven...

GE Aerospace has a $190B backlog (~9 years of revenue) dominated by high-margin aftermarket services. LEAP engine deliveries +28% in FY2025 (record), Defense deliveries +30%, orders +32% YoY. 2026 gui...

NextEra is the world's largest renewable developer with 55 GW in backlog, FPL regulated utility providing balance sheet stability, and 13.5 GW of new projects added in 2025 alone. Battery storage +220...

FY2025 revenue $63.9B (+24% YoY). Gross margin 67.8%, EBITDA margin 67%. FCF $26.9B (+39% YoY). Net debt $49B. AI semis surging: 74% Q4 YoY growth, Q1'26 guidance $8.2B (doubling YoY). Total Q1'26 rev...

FY26 revenue $7.21B (+18%), FCF $2.41B (+54%). AECO grew 22%, direct revenue hit 63% (vs 39% TD Synnex prior). RPO $8.3B (+20%). FY27 guide conservative at 12-13% growth due to sales optimization fric...

AMD Q4 2025: 10.3B (+34%), DC 5.4B. Q1 2026 guide 9.8B. OpenAI + Meta confirmed as Instinct customers. 44.7% upside to analyst mean 290. Bull: rising AI tide + EPYC CPU gains. Bear: NVIDIA CUDA moat, ...

LLY Q4 2025: Mounjaro 7.4B (+110%), Zepbound 4.2B (+123%), EPS 7.54 vs 6.67 est. 2026 guidance 80-83B (+25%). 70% share of new obesity Rx. Oral GLP-1 (orforglipron) Phase 3 next catalyst. Bear: pricin...

AVGO Q1 FY2026: revenue 19.3B (+29%), AI revenue 8.4B (+106%). Six XPU customers locked. CEO sees 100B AI revenue path. 68% EBITDA margin. Conviction 8, 49% upside to analyst target.

New discovery via 200dma screen. LTL pure-play freight cycle. Rich valuation needs vetting.

New discovery via 200dma screen. Aerospace controls + industrial power. Acquisition catalyst. Needs research.

New discovery via 200dma screen. Specialty metals aerospace. Needs research.

Visa stock declined ~11% from ~ highs amid broader market pressure and weaker transaction activity signals. Now at .74, below 200dma. 90%+ of analysts bullish with median target (+29.6% upside). Dire...

Paycom expanded its revolving credit facility by ~.6M to .46B and has .56B remaining in share repurchase authorization. New Career and Succession Planning product launched. Stock at -124, down from a...

Cooper Companies delivered Q1 FY2026 earnings beat with revenue +6% YoY to B and raised Q2 guidance (.58-4.66 EPS). Stock declined 2.2% on mixed reception. Oversold territory with Wall Street expectin...

BWXT reported Q4 revenue beat and 50% annual backlog surge to .3B. Alkeon Capital acquired 978K additional shares (+163% of position). TD Cowen initiated coverage in March. Federal procurement items c...

KTOS surged 6.7% on March 17-18 driven by ongoing contract wins (Counter-UAS, SDA fire control, drone collaborations) and fresh growth outlook from analysts. Valkyrie tactical drone program advancing....

NexGen Energy received final federal approval from Canada's Nuclear Safety Commission for Rook I, the world's largest high-grade uranium deposit. Construction start slated summer 2026. This was the ex...

Q3 FY26 10-Q confirms thesis: subscription revenue +19% YoY, AECO +23%, direct channel hit 66% of revenue (from 42% a year ago). RPO of $7.36B. FCF inflection massive. Full FY26 delivered $7.206B reve...

FOMC day. Brent $103. Hormuz+Fujairah disrupted. Russia-Iran tech axis deepens. KTOS thesis validated by WSJ. NVDA valuation compression continues.

Amazon Q4 2025: $213.4B revenue (+14%), AWS $128.7B run rate, advertising $21.3B (+22% YoY). The $200B 2026 capex commitment signals Jassy believes AWS can re-accelerate against Azure and Google Cloud...

Datadog's Q4 2025 was a blowout: revenue +29% YoY ($953M), 2026 guidance $4.06-4.10B (+19% midpoint), shares +16% in a single session. The AI observability thesis is validating — LLM monitoring, AI ag...

Alphabet is successfully threading the needle between AI disruption and monetization. Q4 2025: +18% total revenue (.8B), Cloud becoming a genuine profit engine (36% growth), advertising reaccelerating...

7th read of same Q1 FY2026 10-Q. Thesis confirmed: rate machine humming (+$122.5M approvals), interest expense collapse structural (-37% YoY from locked AOCI gains), $26B capex plan on track. Risk: st...

IQV 2025 10-K confirms strong data moat (68 petabytes, 1.2B patient records) with deepening platform integration. No single customer concentration risk (largest = 5%). Market tailwinds accelerating (N...

FY2025 revenue .31B (+5.9% YoY), operating income .18B (13.4% margin), net income .36B (8.3% margin). Debt .98B with 3.33x net leverage. Data moat confirmed: 1.2B patient records, 68PB proprietary dat...

Contract value growth 1%, wallet retention down 6-7pts, government revenue collapsed by M. Consulting weakening. Digital Markets divestiture (M) signals restructuring need. Insights segment losing mom...

Filed 2026-02-24. Core distribution 3-4% growth on track. Specialty/Tech accelerating (11.7% + 5.1% of sales). FY guidance raised to .88-.96 EPS (3-4% growth). KKR partnership announced with $200M+ op...

Worldpay transformational deal complete but integration/transformation execution risk elevated above initial estimates. Conviction downgrade 6→5/10.

2025 delivered record rent spreads (15% cash, 27% SL) on 2.5M sq ft leasing. FFO grew 6.6% to .22/share, Core FFO +4.3%. Occupancy 94.5% is healthy. 2026 guidance .42-7.52 (+5.1-6.5%) suggests modest ...

LLPS now operational with 4 large customers signed. Bull case validated. 2026 +10.7% EPS growth credible. Bear case risk: capex execution, debt levels, interest coverage. Holding 7/10 conviction—prove...

Recurring revenue growing 7% organically (9% reported), but ICS margin compression from postage rate increases offset GTO strength. Digital asset holdings (.8M Canton Coins) and Tharimmune warrant inv...

DVN 10-K 2025: Capital discipline-focused independent E&P with strong FCF generation (.7B OCF, .1B FCF). Grayson Mill integration on track, B business optimization plan 85% achieved. Coterra merger (a...

ATO Q1 FY26: Rate execution validated (+$122.5M approvals), interest expense collapsed 37% YoY, capex ramping with tight recovery mechanisms in place. Consolidated net income +14.5% to $403M, EPS +9.4...

Stock down 42% from 52w high ($161→$93). Bears: AI threatens payroll commoditization, Paycor integration messy, organic growth weak. Bulls: fPE 15.8x cheap for quality, 24% analyst upside to $115, $12...

Q1 FY2026 record: $669M sales (+9%), ATS segment +20% organic driven by semiconductor capex. AI computing driving dispense and x-ray demand. fPE 21.8x fair but not cheap. 16% analyst upside to $312. C...

Q2 FY2026 earnings Wed Mar 18 — 97% probability of beat per prediction markets. Guidance: $18.7B revenue, $8.42 non-GAAP EPS. HBM 2026 fully booked. Taiwan fab acquisition ($1.8B) closed mid-March. Bu...

Paycom expanded credit facility by .6M through JPMorgan Chase to .46B total. Neutral-to-positive liquidity move. No strategic change to HCM thesis.

Alkeon Capital acquired 978K additional BWXT shares (+163% increase). Follows Q4 revenue beat and 50% YoY backlog surge to .3B. TD Cowen initiated coverage. Strong institutional conviction building ar...

KTOS surged 5.88% on Q4 earnings beat. New ~M Counter-UAS production contract, Space Development Agency Advanced Fire Control program completing Critical Design Review, drone collaborations expanding....

Insulet presented EVOLUTION 2 trial results showing 68% TIR for fully closed-loop automated insulin delivery in Type 2 adults at ATTD conference. Positive clinical validation of T2D market expansion t...

Board asked KPMG (auditor since 2016) to resign March 5, appointed PwC. No reportable events, no modified opinions — company characterizes as planned governance-driven change. Yellow governance flag t...

ATO delivered strong Q1 results with revenue up 14.2% and net income up 14.5%, driven by 122.5M in rate approvals and a dramatic 37% collapse in interest expense. The company is executing on its regul...

DVN delivered .7B operating cash flow on 14% production growth (Grayson Mill + organic), but net earnings fell 7% YoY due to 14% oil price decline to .87/Bbl. Debt-to-cap 24.8% remains fortress-like p...

BR shows steady 10% revenue growth with strong cash generation, but core business (ICS) is decelerating to 7% recurring growth while postage inflation pressures margins by 4 points. GTO growth is acqu...

FY2025 10-K confirms solid execution: revenue $10.7B (+5.4%), Banking +6%, Capital Markets +7% at 51.8% EBITDA margins. Issuer Solutions acquisition ($7.7B debt, Jan 2026) funded by Worldpay 45% stake...

FY2025 10-K confirms thesis: LLPS approved (KCC+MPSC Nov 2025), 1,900MW data center ESAs signed Feb 2026, .6B 2026-2030 capex. But financials show strain: adj EPS barely grew (.81→.83), GAAP EPS decli...

FY2025 revenue $4.02B (-1.6% organic), non-GAAP EPS $10.28 (flat). Core DSA/RMS margins held; CDMO/Biologics Solutions destroyed $376M value via impairments Q4 alone ($380M goodwill over 2 yrs). FCF s...

Q1 FY2026 (Dec 31, 2025): Revenue +14.2% to $1.343B, net income +14.5% to $403.0M, EPS $2.44 diluted. Rate approvals: +$122.5M annual operating income in Q1 alone (formula rate mechanisms +$145.7M, ra...

Cable EBITDA +4.6% YoY on pricing power. TV EBITDA -30% in Q2 as sports costs bite hard. FOX One streaming losses widening in Corp/Other (-$138M vs -$81M). Revenue +2% consolidated. $1.8B buyback in H...

POWL Q1 delivered exceptional operational execution with 380bps gross margin expansion to 28.4% and .5M positive contract estimate revisions. $1.6B backlog (M in next 12mo) provides strong demand visi...

BR Q2 FY2026 earnings growth boosted 102% by digital asset gains (~$235M), masking 3–5% underlying operational growth. Recurring revenue growth solid at 9%, but closed sales declined 13% YoY. ICS marg...

DVN delivered 14% production growth (737→840 MBoe/d) from Grayson Mill acquisition, but earnings down 9% due to 14% oil price decline. Generated .1B FCF with 11% yield; 24.8% net debt-to-cap ratio mai...

FY2025 adj EPS $3.83 vs $3.81. GAAP EPS $3.66 vs $3.79 due to clean energy investment losses (being disposed). Revenue +2% to $5.96B. 5-year capex plan of $21.6B including $9.3B new generation. Critic...

FY2025 revenue $4.02B (-1.6% organic). Non-GAAP EPS $10.28 (flat). CDMO+Cell Solutions divested to GI Partners for contingent payments (~zero upfront), European Discovery assets sold to IQVIA for $145...

FY2025: Revenue .46B (+15.4% reported, +4.9% organic constant currency). GAAP op margin compressed 11.5%→9.5%; Non-GAAP margin 16.5%→15.2%. Net income .7M (down from .5M). Cash .30B, near-zero debt. M...

FY2025 confirms operational superiority: 307 MMBoe production (+14% YoY), $3.1B FCF, 193% reserve replacement at $6/Boe F&D. Coterra merger (Feb 1, 2026) adds $1B synergy target by YE2027, 31% dividen...

Q1 FY2026 (Dec 31, 2025): Revenue +14.2% YoY to $1.34B, net income +14.5% to $403M, EPS $2.44 diluted (+9.4%). Rate approvals of $122.5M annual op income in Q1 alone. Capex accelerating to $1.03B in Q...

Re-read confirms Q1 FY2026 thesis. Critical nuance: $10.5M contract estimate revisions inflated gross margin ~420bps. Underlying margin ~24-26% is the right baseline. Electric utility +35% YoY now 27....

Q2 FY2026 (ended Dec 31, 2025): Revenue +8% to $1.71B. Recurring revenue +9% organic. GTO segment pre-tax margin expanded to 16.1% (from 11.3%) — key positive. ICS pre-tax margin compressed to 11.1% (...

FY2025 10-K: Revenue $4.53B +13.9% (10% organic). Corporate Payments surged 33.8% driven by Alpha (Oct 2025) and AvidXchange (May 2025). Adj EBITDA $2.57B at 56.6% margin (slight compression from M&A ...

Solid organic growth (6-7% recurring revenue) but ICS margins compressed 140bps by postage inflation. Digital asset gains (Canton Coins) inflating reported earnings by ~M H1 — a distraction masking st...

FY2025 10-K shows strong recurring revenue growth (+13.9% reported, ~10% organic) with margin compression from Alpha deal. Proprietary networks in fuel/tolls/EV charging + cross-border FX business cre...

Merck is a dominant oncology franchise with Keytruda at 49% of sales. Gardasil China exposure fully wiped out. Winrevair scaling. The 2028 Keytruda patent cliff is a real, known risk. Conviction 5: ch...

GE Vernova is a dominant power infrastructure franchise with $150B backlog and 83 GW gas turbine book through 2029. Power and Electrification segments exceptional; Wind structurally challenged. Convic...

Intel executing 5-node roadmap with 18A in HVM. Agentic AI creating surprise CPU demand tailwind. Foundry losses the key risk. Conviction 6: real option value on process recovery but execution uncerta...

EOG flashed a bullish golden cross (50dma above 200dma). Paul Tudor Jones and Israel Englander both disclosed EOG positions. Capital International sold 62% of stake (offsetting factor). Positive techn...

BWXT Q4 earnings beat expectations. Backlog grew 50% YoY to $7.3B — strongest single data point confirming multi-year visibility. TD Cowen initiated coverage. Incremental positive confirmation of 10-K...

Multiple analyst pieces questioning META's $115-135B AI capex plan for 2026, arguing it will compress FCF and valuations. Stock down ~17% from recent highs. Counter-argument: META is best-in-class Mag...

Insulet issued a voluntary correction for specific Omnipod 5 pod lots due to a small internal tubing tear causing insulin delivery failures. 18 serious adverse events including hospitalizations and DK...

10-K deep read complete. Filing marked read. Iran war catalyst raises WTI 28% to ~-96 post-filing, fundamentally improving 2026 earnings trajectory. Conviction raised 6→7.

Q2 FY2026 recurring revenue +9% (8% CC, 7% organic). Adj EPS $1.59 (+2% YoY). FY2026 guidance raised: adj EPS growth 9-12%, recurring revenue higher end of 5-7% CC. GAAP EPS boosted by $187M digital a...

FY2025 10-K (period 12/31/2025, filed 2/27/2026). Revenue .53B (+13.9%, 10% organic). Corporate Payments surged 33.8% to .64B driven by Alpha Group (UK cross-border FX, .4B) acquired Oct 2025. Vehicle...

Adjusted margin hits exactly 25% thesis target. Net flows turned positive (+$26.8B) — first meaningful inflection in years. WAM DOJ heading to non-criminal resolution (CFTC closed). EPS +19% YoY on ad...

Q1 FY2026 (Dec 31, 2025): Revenue +14.2% to .34B, net income +14.5% to M. Standout: interest charges DROPPED 37% (M → M) due to locked-in hedge gains. Capex .03B in Q1 alone. Debt/cap 41%. .09B in for...

Q1 FY2026: Revenue $251M (+4% YoY), gross margin 28.4% (+370 bps), EPS $3.40 (+19%), backlog surges to $1.6B (from $1.4B), electric utility revenue +35% to $69M (27.6% of mix). Cash $491M, zero debt. ...

GNRC FY2025 revenue declined 2% to $4.21B, driven by a 6.8% residential drop (low outage activity, tough hurricane comp) offset by 4.9% C&I growth and 6% international growth. Adj EBITDA fell 9.3% to ...

FY2025 10-K confirms record adj. OI $2,461M (12.1% margin), $20.4B revenue (+3.5%). Versigent (EDS) spin April 1 confirmed with debt priced. Post-spin New Aptiv (ASUX+ECG) targets 18.6% EBITDA vs 12% ...

Syntec Optics is a Rochester NY-based precision optics manufacturer with growing exposure to high-value defense contracts: missile guidance, night vision (ENVG-B), AR/XR battlefield systems, and LEO s...

Casey's is a 'pizza chain that sells gas' with a genuine geographic moat in rural/small-town America. 5th largest pizza chain in the US. 60% owned real estate. 14% CAGR over 10 years. Post-Fikes acqui...

TechnipFMC is best-in-class subsea OFS with differentiated iEPCI model, record $16.6B backlog, and 2026 guidance implying 15% EBITDA growth. Direct award share >80% signals structural moat. FCF inflec...

FY2025 revenue $4.21B (-2% YoY) masks accelerating quality improvement: C&I +4.9% data center-driven, gross margin 38.3% (up 450bps from 2023), Adj EBITDA $718M at 17% margin. GAAP earnings badly dist...

Versigent spin confirmed April 1 with debt financing priced early March. New Aptiv (ASUX+ECG) FY26 adj EPS guide .70-6.10 at current implies 12x P/E — historically cheap for an industrial tech compan...

FY2025: Revenue +18.3% to $3.2B, backlog +50% to $7.26B, two transformative acquisitions. Margin compression is temporary integration noise. Naval monopoly intact. 0% convertible at $262.51 = manageme...

FY2025 results confirm thesis: .347B revenue (+18.5%), EBITDA .9M (8.9%). FY2026 guidance .635B midpoint (+21%). Three franchise-level programs — Valkyrie CCA (Program of Record), MACH TB 2.0 (.45B hy...

FY2025 10-K confirms a transformational year. Revenue +43% to record $1.03B, OCF +33% to record $704.8M. Portfolio asset base nearly tripled via Sandstorm+Horizon acquisition ($4.15B) and Kansanshi go...

Q1 FY2026 (ended Jan 31, 2026): Revenue $1,024M (+6.2%), op income $212.8M (+17% / +190bps), net income +25%. CVI +7.6% with toric/multifocal +9.9% confirming premium mix shift. CSI +3.3% with fertili...

Record revenue $1.03B (+43%), OCF $704.8M (+33%). Sandstorm+Horizon acquisition ($4.148B, Oct 2025) plus $1B Kansanshi stream doubles portfolio book value to $8.58B. FY2026 is first full year of combi...

Jacobs has completed its transformation: CMS/cyber sold to Amentum (received $70M + AMTM shares), full PA Consulting acquisition announced Jan 2026 at £1.2B/$1.6B. Result: a pure-play professional ser...

RJF is a wealth management fortress currently trading BELOW its entry target. Q1 FY2026: net new assets $31B (8% annualized — second-best ever). Revenue reacceleration projected to 7-11% in H2 2025-H1...

FICO controls a regulatory mandate for its score in US mortgage underwriting. FY2025: $1.99B revenue (+16%), Scores $1.17B (+27%). 2026 catalyst: FICO doubled mortgage scoring fees (~$4.95/score + $33...

BWXT opened its Centrifuge Manufacturing Development Facility in Oak Ridge, TN — a milestone toward reestablishing fully domestic uranium enrichment capability. Reinforces defense/energy dual-use thes...

Meta acquired Moltbook, a social networking platform built for AI agents — bringing founders in-house. Signals META building an AI agent platform layer on top of social graph. Concurrently, UK and US ...

Insulet presenting clinical results for Omnipod fully closed-loop (FCL) system in type 2 diabetes at ATTD 2026 in Barcelona today. This is new clinical data for their T2D FCL expansion — a major thesi...

GTC 2026 (March 16-19, San Jose) is a major catalyst event 5 days out. Jensen Huang published AI-as-infrastructure blog framing. Separately, NVDA announced a partnership with Thinking Machines Lab pro...

FDA clearance for Smart Basal extends DXCM's TAM into type 2 diabetes basal insulin management, pairing CGM data with dosing guidance. Thesis-accretive: T2D is 10x the T1D market and historically unde...

Falcon re-read confirms: revenue .2B, operating income M (+18.8%), net income M (+26.1%). NAST volume +7.6% vs Cass index -7.6% — clear market share gains. Adj GP ,589M (-1.7%). Lean AI driving real p...

Falcon re-read confirms: net sales .08B (+19.3%), gross margin 38.4% (+370bps). Donaldsonville CCS online (M, 2M tons CO2 capture). Blue Point JV .7B total (.5B CF share), 2029 startup. Yazoo City AN ...

Falcon re-read confirms: ~.8B revenue, 7% recurring growth. GTO margin 15.4% and expanding. Adj EPS .55 (+11%). Debt ~.5-4B (2.5-3x leverage). 19 consecutive dividend increases. AI products (BondGPT, ...

Falcon re-read confirms: revenue .76B (+22.5%), but heavily inorganic (43 acquisitions, RSC/Accession). Organic growth likely 8-12% (not explicitly disclosed). Total debt .6B post-RSC financing. FG Po...

Falcon re-read confirms strong FY2025: net revenue +17.8% to .43B, Q4 +28%. EBITDA margin 69.2% (+610bps). Net cash M. Index options ADV +35%, zero-DTE now 60% of SPX volume. 2026 guidance conservativ...

40-F for FY2025 (equivalent to 10-K). CNSC construction license received March 5, 2026 — final regulatory approval. C$1.12B liquid + C$341M uranium inventory. Capex C$2.2B (up from C$1.3B). 4-year con...

FY2025 confirms NA franchise strength (24.4% margin, +1.4% revenue) and China restructuring effectiveness (margin 8.7% vs 7.0% on -12% revenue). Key new factor: Leonard Valve acquisition (M term loan,...

10-K confirms thesis: FY2025 revenue .1B (+9%), gross margin expanded to 29% (from 27%), net income .7M (+21%), EPS .86. Fortress balance sheet: M cash, zero debt. Backlog .4B (+3%). Revenue diversifi...

FY2025 revenue .21B (-2% YoY) — residential weak (-6.8%) on low-outage environment, C&I up 4.9% driven by data center and telecom. Gross margin 38.3% (-50bps). GAAP operating income collapsed (M vs M)...

Q4 2025: $1.89B revenue (+16% YoY), 16.7% gross margin — strong beat. FY2025: $6.71B (+6%), $374M net income, $1.50 EPS. Net cash: $546M. Q1 2026 guide: $1.60-1.70B, 12.5-13.5% GM (seasonal). 2026 cap...

FY2025: $1.347B revenue (+16.6% organic), $119.9M EBITDA (8.9%). 2026 guidance $1.595-1.675B, EBITDA ~10%. CRITICAL: Northrop won MUX TACAIR CCA with Valkyrie as the aircraft — program of record confi...

10-K confirms FY2025 record results: $20.4B revenue (+3%), $2,461M adj OI (12.1% margin, record), adj EPS $7.82 (+25% yoy). Wind River $648M goodwill impairment non-cash. ASUX segment stalling (flat r...

Second confirmation pass on FY2025 10-K (filed Feb 19, 2026, acc# 0000085535-26-000008). No new 10-Q available until ~May 2026. Filing intact with prior analysis. Key incremental focus: revenue concen...

FY2025: Revenue +18.3% to .2B. Backlog surges 50% to .26B. Two major acquisitions (A.O.T, Kinectrics). Issued $1.25B 0% convertible notes. Naval monopoly thesis intact, commercial becoming major growt...

BWXT posted 18% revenue growth to $3.2B and 50% backlog expansion to $7.3B in 2025, driven by naval reactor monopoly (73% revenue, 20%+ margins) and surging commercial nuclear/medical business (63% gr...

KTOS: $1.57B backlog (1.8x book-to-bill), $870M revenue, backlog-driven growth. Valkyrie + target drones + hypersonic (MACH TB 2.0 $1.45B) core growth drivers. Moat: first-to-market, design-in positio...

AMKR tripling capex to $2.5-3B in 2026 to relieve HDFO bottleneck for AI/HPC packaging. Advanced packaging drives >20% segment growth, but Apple/Qualcomm concentration and Arizona ramp are risks. Thes...

Operationally stabilizing (losses down 21% YoY) but turnaround unproven. $823.5M RPO strong, but 4.4% Q2 revenue growth minimal and margin compression continues. Deeply unprofitable with 2-3 year runw...

POWL Q1 FY2026 crushing margins (+380 bps) on 4% revenue growth. Strong backlog ($1.6B, $933M in 12m), fortress balance sheet ($491M cash, zero debt), favorable contract revisions ($10.5M). Traditiona...

MOD's data center business accelerating (+45.5% 9M) but margin profile weakening from acquisitions. Debt spike to .7M manageable with CF gen, but leverage elevated 2.5x. Performance Tech segment stall...

CVX FY2025: Record 3.7M BOE/day production (+12% YoY). Q4 4.05M BOED (+21%) including full Hess ramp. Permian hit 1M BOE/day. 10.6B BOE reserves (+8%), 158% replacement ratio. Q4 adj EPS $1.52 vs $2.0...

FY2025 confirms the spin thesis — Versigent EDS separation on track for April 1 (record date March 17). NuAptiv post-spin will show 18.6% adj EBITDA margin vs 12% blended today, a step-change that sho...

FY2025 10-K confirms RGLD as the cleanest gold leverage vehicle. Record $1.03B revenue (+43%), $704.8M OCF (+33%). Sandstorm acquisition ($4.15B, Oct 2025) doubled the portfolio to $8.58B in stream/ro...

Q3 FY26 10-Q validates the core thesis on all dimensions: AUR elevation structural (high-teens NA, mid-teens Asia), Asia segment on fire (+22.4% revenue, +490bps margin), gross margin at 69.9% (+150bp...

GNRC missed Q4 on residential weakness but data center C&I segment +10% and backlog grew to M. 2026 guidance: mid-teens revenue growth, C&I +30%+. The outage environment trough is likely behind us. Da...

ON navigating through the automotive inventory trough while AI data center revenue accelerates. SiC/GaN moat intact. B buyback signals management conviction. Key inflection: auto stabilization + AI da...

RL executing luxury brand elevation with precision. AUR +18%, China +30%, op margin +200bps. DTC shift and pricing discipline structural. Entry target 320-325 on 200dma retest.

FY2025 10-K confirms EOG executed a major strategic pivot via the 5.7B Encino Utica acquisition, delivering 16% YoY production growth to 450 MMBoe. Net income declined 22% to 5.0B on oil price pressur...

FY2025 adj EPS $4.69 (+1% YoY). 2026 guidance $4.80-$5.30. 2030 outlook $6.70-$7.50 (8% CAGR). $65B 5yr capex plan (95% regulated TX/CA). KKR deal ($10B for 45% SI Partners) expected Q2-Q3 2026. Major...

2025 10-K confirms the FCF inflection thesis. Encino acquisition (.7B, 675k Utica acres) expands EOG's inventory. Production +16% YoY to 449.8 MMBoe. Oil -15% hurt revenue, but gas +39% partially offs...

EOG's 2025 10-K confirms the Encino acquisition transformed the production profile (+16% YoY to 450 MMBoe), while 2026 capex collapses from $13.6B to $6.3-6.7B — setting up the largest FCF expansion i...

Encino transforms EOG into true integrated Permian/Appalachian platform. Prod +16% reserves, but oil price down 15% compressed 2025 earnings. Debt elevated (21% cap) but normalized 2026 capex ($6.3-6....

Cheapest of the trio at 0.82x P/S. EMS giant pivoting into AI data center platform assembly (AMD GPU deal). Revenue +12% TTM. Bull: re-rate if AI manufacturing scales. Bear: low-margin EMS history. Mo...

High-quality defense/nuclear compounder. FY2025 record results. 2026 guidance strong ($14.93 EPS midpoint). Valuation stretched at ~$706 — priced for 2030 earnings. Strong watchlist candidate; wait fo...

Lumentum is optical backbone of AI data centers. OCS tech is key catalyst — $100M/q target by end 2026. Post-900% run valuation is the primary risk. Fascinating business, difficult entry.

Lumentum is the optical backbone of AI data centers. OCS tech is the key catalyst — $100M/q target by end 2026. Post-900% run valuation is the primary risk. Fascinating business, difficult entry.

FY2025: .4B rev (+3.5%), record adj. OI .461B (12.1% margin), but M Wind River goodwill impairment dragging GAAP to M net income. Versigent spin confirmed April 1 (record Mar 17). NuAptiv post-spin: ....

Full 10-K read. FY2025 adj EPS .16 (vs .79 in 2024, -21% YoY) on lower realized prices (.01/BOE vs .83). Production grew 2.5% organically to 2,375 MBOED thanks to Marathon integration. Marathon synerg...

FY2025 10-K confirms thesis. Record .03B revenue (+43% YoY), record .8M OCF. Sandstorm acquisition (.1B, Oct 2025) doubled stream/royalty asset base to .6B. Gold leverage intact: avg price ,432/oz dro...

FY2025: Revenue .6B (-5%), adj net income .5B (.16/share), FCF .7B. Encino acquisition (Aug 2025) added 1.1M Utica acres, cost .5B funded by debt — net debt now .54B vs prior net cash. Production +16%...

FY2025: Rev .735B (-3% YoY, Olympics timing), Adj EBITDA .585B (+47%), net income M vs. M loss prior year, FCF .159B. UFC .502B (+7%), WWE .709B (+22%). 2026 guidance: Rev .675-5.775B (+21%), EBITDA ....

AOS stable industrial with 38.8% gross margin, 24.4% NA segment margin. China (-12% local currency) drag continues but restructuring improved ROW margin to 8.7%. FCF M. 2026 guidance +2-5% revenue, EP...

Callon synergies on track (cost reductions, efficiency gains). Egypt Jan-2025 gas agreement (.65/MMBtu floor + incremental pricing) is game-changer—materially improves cash flow. 30% PUD reserves prov...

FY2025 operational excellence (20.4B rev, 15.8% EBITDA) confirms scale moat. EDS spin (Apr 2026) shifts to higher-margin software-first positioning with 18.6% post-spin EBITDA target. Autonomy (L2/L3)...

FY25 revenue .21B (+5% YoY). Security .24B (+10%), Delivery .26B (-5%), Cloud M (+12%). Cloud Infra Services grew 36% to M. Non-GAAP op margin 30%, EBITDA margin 43%. OCF .52B. .9B cash/securities. .7...

Falcon deep read: Revenue .1B (CVI .74B +4.9%, CSI .35B +4.0%). Organic growth 3.2% vs 5-6% original guidance — deceleration real. Gross margin 65.5%. Premium drivers strong: MyDay Multifocal +20%, To...

Falcon deep read: Revenue .8B (+7.9% YoY). Global Housing .9B (+12.6%, 29.5% EBITDA margin, .7M EBITDA +27.9%). Global Lifestyle .9B (+6.6%, 8.1% margin). Net income .7M (+14.8%). Debt .2B, 27.3% debt...

Falcon deep read: Est ~.9B revenue post-Endeavor acquisition (UFC ~M, WWE ~M, IMG ~M, On Location ~M, PBR ~M). 500+ events, 1B+ households, 2B+ fans. Media rights appreciation (Paramount 7yr UFC, Netf...

Falcon deep read: Revenue .1B 9M (67% non-regulated, 33% regulated). Margin compression -250bps (20.3%→17.8%) from non-reg revenue decline, emissions cost surge (M vs M), Chile tariff caps. OCF strong...

Falcon deep read confirms: 6.9% organic (residential ~5%, commercial ~8%, termite ~10%), 52.8% gross margin (+10bps), 20% adj op margin (+10bps), M FCF (+12.1%, 123% conversion). 75% recurring revenue...

AEE FY2025 10-K confirms thesis with conviction-raising data: EPS +21% to $5.35 (exceptional for utility), 2.2 GW data center demand agreements signed Feb 2026, $31.8B 2026-2030 capex plan, dividend r...

FY2025 10-K: Net income .16B (+8%), EPS .07 (+18%). Life margins expanding (45% reported, 41% normalized vs 40%). Medicare Supp surge (+36% health net sales). Excess investment income declining -16%. ...

FY2025: Revenue $3.761B (+11%), organic growth 6.9%, adj operating margin 20.0% (+10bps), adj EBITDA $855M (22.7%), FCF $650M (+12%). 26 acquisitions/buybacks including Saela. 2026 guidance: 7-8% orga...

FY2025 10-K confirms margin expansion thesis. WE DO transformation fully complete (zero restructuring/T&T charges vs $470M in 2024). Organic revenue +5%. Adjusted op margin 25.2% (+130bps). FCF $1.55B...

FY2025: Rev .735B (-3% YoY due to Olympics comp), Adj EBITDA .585B (+47%), margin 33% vs 22%. UFC +7% rev, 57% margins. WWE +22% rev, 52% margins. FY2026 guidance: Rev .675-5.775B (+21%), EBITDA .240-...

Q1 FY2026 (ended Jan 31, 2026): Revenue ,024M (+6.2% YoY), operating income M (+17% YoY), net income M (+25%). CooperVision +7.6%, CooperSurgical +3.3%. OCF surged to M vs M. Gross margin flat at 68%....

Illumina is the dominant genomics sequencing platform (NovaSeq X), executing a clinical pivot that drove Q4 2025 EPS beat ($1.35 vs $1.23 est) and revenue beat ($1.16B vs $1.10B est). Clinical consuma...

Royal Gold is a high-margin royalty/streaming company with zero mining operating cost. Record FY2025 revenue $1.03B (+43% LTM), Q4 revenue $373M (nearly doubled YoY). 25th consecutive annual dividend ...

COHR is the optical backbone of AI infrastructure — vertically integrated photonics leader capturing the 800G→1.6T transceiver upgrade cycle. NVIDIA $2B partnership (March 2026) is transformative. Bul...

Leadership stability confirmed with Sayer returning to Executive Chairman role. Presented at Raymond James conference. High IV in options near March 20 expiry - possible catalyst expected by market.

New Maryland rate approval and CA infrastructure work confirm regulatory support thesis. 2026 EPS guide $6.02-$6.12 (8% growth target) affirmed. Positive incremental datapoint.

Confirms 10-K thesis: China is officially foreclosed. The capacity shift to Vera Rubin (next-gen) is bullish — TSMC bandwidth getting redeployed to higher-value chips sooner. Net neutral-to-positive; ...

SRE at $91.66 has rallied ~45% from 52w low on trough-year clarity + KKR deal + Oncor growth. Forward PE 16.6x on $5.52 consensus is reasonable but not cheap. Analyst mean $101.50 is 10% upside — insu...

SRE FY2025 was a messy year: EPS dropped from $4.42 to $2.75 due to one-time hits (GRC disallowances $432M, $703M deferred tax from SI Partners held-for-sale reclassification). Stripping those out, th...

DG at 146.55, down 3.3% today and 40% from peak. Turnaround progressing (SSS 2.5%, shrink improving) but 15% global tariff surcharge hits China-sourced SKU COGS meaningfully. Q4 FY2025 earnings March ...

LDOS beat Q4 2025 with record FCF and 680bps margin expansion. 2026 guidance 17.5-17.9B. DOGE bear case overstated — defense IT is mission-critical, not discretionary. FCF engine and margin expansion ...

NXE received final federal CNSC approval for Rook I on March 5, 2026 — the last regulatory hurdle. Construction begins summer 2026, production ~2030. The mine will produce 30M lbs/yr (>20% global uran...

FY2025: .2B revenue (+6%), net income B (+19.5% — but .7B tax artifact from State Aid reversal inflates headline). Normalized NI growth ~7-8%. Services .2B (+14%) at 75.4% gross margin is the thesis e...

FSLR delivered record module sales (17.5 GW, +24%) and record net sales ($5.2B) in FY2025. EPS $14.21. Net cash surged to $2.4B. The 50.1 GW backlog ($15B) provides exceptional forward visibility. Cri...

Blowout Q1: $143.8B revenue (+16%), $42.1B net income (+16%), 48.2% GM (+130bps). iPhone +23% on Pro mix. Greater China +38% — the single most important datapoint, reversing prior weakness thesis. R&D...

FY2025 confirms quality story: 91% retention (best ever), zero debt, OCF +27% to $679M, FCF ~$410M. Headline margin compression from $141M SBC accounting distortion. Revenue growth at ~9% is real dece...

FY2025: Revenue +24% to $5.2B, Adj EBITDA $2.36B, diluted EPS $14.21, gross cash $2.9B. 2026 guidance: revenue $4.9-5.2B (flat), EBITDA $2.6-2.8B (+15-20%). At $191, FSLR trades at 6.7x 2026E EV/EBITD...

Alphabet's FY2025 10-K reveals two surprise positives: Search growing 13% despite AI competition (thesis-confirming) and Google Cloud doubling operating income to $13.9B (+127%) while scaling to $58.7...

Best-in-class specialty P&C insurer. NPW +6.2% to $12.7B, combined ratio 90.7%, investment income +7.2% to $1.43B. Income before taxes essentially flat YoY ($2.28B vs $2.26B) despite premium growth — ...

Blowout Q1: $143.8B revenue (+16%), $42.1B net income (+16%), 48.2% GM (+130bps). iPhone +23% on Pro mix. Greater China +38% — massive reversal. Services $30B (+14%) at 76.5% margin. R&D surged +32% t...

Revenue +9% to .05B. OpInc -10.6% to M (27.6% margin) — BUT this is distorted by M SBC accounting swing (2024 had M reversal that didn't repeat). Normalized OpInc ~+15%. OCF +27% to M, FCF ~M. Zero de...

Q1 FY26: Revenue +21% YoY to .8M. License surge +56% YoY to M drove 1,180bps GAAP op margin expansion to 32.2%. Non-GAAP op margin 45.1%. FCF M. Kepware/ThingWorx divestiture (M+) on track for close b...

Q1 FY26 (Dec 2025): ARR +13% to $2.49B (8% CC), revenue +21% to $686M driven by 56% license surge. Operating margin expanded 1,180 bps to 32.2%. FCF $267M (+13%). Divesting Kepware/ThingWorx for up to...

FY2025 10-K confirms strong execution. Revenue +30.7% to $2.71B (const curr +29.5%). Gross margin 71.6% (+180bps). Adj EBITDA $645.5M (+41%). FCF $377.7M. Deleveraged 40% (debt $949M from $1.38B). Net...

FY2025 results exceed expectations: premium +5% to $4.89B, net income +8% to $1.16B ($14.07 EPS), life margins expanded to 45% (from 41%). Operating ROE 16%. Strong capital position with 316% RBC rati...

2025 adjusted EPS .58 vs .87 in 2024 (-3.7%). Revenue flat at .9B. Aerospace up double-digit with M backlog. Auto refinish structurally challenged. 2026 organic guidance flat to low single-digit. Stro...

Strong operating performance with 5% premium growth, 18% EPS growth to $14.07. Life margins expanded to 45% on favorable mortality/assumption updates. Health benefiting from Medicare Advantage-to-Supp...

8% volume growth offsets 8% price/mix decline, keeping sales flat. Gross profit up but masked by Argentina startup costs and softer JV earnings. Capital intensity declining as expansion projects compl...

Paycom FY2025: High-quality SaaS with 91% net retention, expanding beyond payroll toward mid-market enterprise. Single-database moat and in-house R&D competitive advantage. Geographic expansion room (...

MTCH 10-K shows painful user traction loss from 2025 portfolio pivot toward higher-intent/safety-first positioning. Tinder core brand under stress. Restructuring underway to offset revenue pressure vi...

Campbell's faces near-term tariff headwinds (-200 bps margin, -$.04 EPS) but cost savings (M runway) and valuation (9.7x fwd) offer medium-term recovery opportunity. Rao's growth offset by core soup/s...

Medical cost inflation crisis (MCR 91.7%) offsets strong revenue growth. Strategic pullback from Medicare MAPD and low-margin Marketplace to focus on Medicaid. Earnings remain pressured in 2026-2027 b...

EPAM: Quality tech services with AI growth thesis, but geopolitical+margin compression risks warrant caution. Diversified client base and excellent attrition are structural strengths.

POOL 2025 10-K shows post-pandemic normalization with flat revenue, stable gross margin, but declining operating income. Maintenance products resilient; new construction and remodeling under pressure ...

FY2025 marked a strategic inflection: Mosaic aggressively divested underperforming assets (Patos de Minas, Taquari, Carlsbad) while refinancing debt at higher rates (4.35-4.60%). Revenue headwinds fro...

Q1 solid on organic growth (6%) and user/client additions, but operating margin compressed 200 bps YoY due to acquisition amortization and tech spending. IT controls weak but remediation in progress. ...

SWKS Q1 FY2026: -3.1% revenue (customer loss offset by Wi-Fi gains), 41.3% gross margin (mix-pressure), operating margin collapsed 17%→10% due to +15% R&D investment in next-gen tech. Strong OCF .5M. ...

CRL reported FY2025 revenue of .0B with earnings-neutral demand environment. DSA segment dominates (59.8% revenue) facing pricing pressure and elevated competition. RMS remains stable with 21.1% contr...

TECH flat organic growth stalled at flat. Margin compression from unfavorable product mix. Exosome divestiture successful at improving Diagnostics segment (10.4% margin post-divestiture vs 3.9% pre). ...

CAG Q2 reveals structural deterioration masked by prior optimism. Massive impairments (M) in Refrigerated & Frozen and core brands (Birds Eye) indicate fair value is below book and zero margin for saf...

ARE 10-K shows headwinds: occupancy 90.9% vs 95% 10yr avg, 45% dividend cut signals confidence loss. Tenant funding constraints post-SVB, construction cost inflation, 3.5M RSF execution risk. Concentr...

Goodwill impairment reflects structural volume decline & category shift risk. Mature market exposure + concentrated brand mix = limited upside. Restructuring execution uncertain. Tariffs + labor costs...

HSIC 10-K: Mature distribution leader with favorable demographics and cost-containment tailwinds. Core dental distribution under mix pressure; specialty products and technology segment growth accelera...

FRT 2025 10-K shows a mature REIT managing through elevated costs. Core NOI growth (6.1%) masks rent-growth resilience (+15% on new leases) offset by structural cost inflation. Portfolio strength (96%...

NCLH occupancy declining despite revenue growth, signaling demand softening. Leverage elevated at 7.5x ND/EBITDA; debt maturity wall 2026-2027 dependent on capital markets. Unhedged euro exposure on $...

BAX FY2025 10-K: Post-divestiture portfolio focused on 3 core segments. High leverage (.48B debt), dividend cut (to /bin/zsh.01), supply disruption from Hurricane Helene, Novum LVP quality hold. Hillr...

Office REIT navigating hybrid work transition. Strong capital structure and development pipeline, but elevated office vacancy and tenant demand uncertainty persist. Multi-year recovery trajectory.

MGM 2025 10-K shows domestic recovery, Macau stabilizing, strategic clarity on Japan/digital/UAE growth. Balance sheet leveraged; execution risk on 2026 labor and Macau concession terms. Premium brand...

FY2025 margins expanded despite flat revenue, driven by pricing and product mix. North America resilient; China distressed. Management taking action on China assessment. Balance sheet strong, cash gen...

Revenue growing 6.9% YoY but net income declining 4.1%—tariff headwinds compressing 280 bps of operating margin. Deferred revenue and services growth encouraging, but margin mitigation plan execution ...

AES Q3 2025 shows stable but compressing business with operational execution intact but margin pressure. Revenue flat, costs rising faster. Refinancing well-positioned. Key risks: Uplight impairment s...

DaVita's 2025 10-K reveals a mature, volume-constrained dialysis business. ESRD patient growth <1%, offset by labor cost inflation. Commercial payor segment (highest margin) under negotiation pressure...

BLDR faces cyclical housing demand downturn. FY2025 revenue -7.4%, margins -240bps, earnings -60%. Industry forecasting flat starts for 2026. Well-positioned operator but cyclical headwinds dominating...

Q3 2025 saw strong recovery with M net income (vs. M loss Q3 2024), but YTD shows Macau structural challenges: revenues down 0.2%, Wynn Macau EBITDAR down 11.7%. Wynn Palace momentum (VIP win % 4.68%)...

RVTY FY2025 reveals slowing growth (4% revenue) against backdrop of tariff headwinds ($25M cost), margin compression (gross margin -104 bps), and inventory/working capital normalization. Life Sciences...

APA consolidating Permian position post-Callon, demonstrating cost synergies while Egypt gas agreement materially improves margin profile. North Sea exit removes drag. Disciplined capital allocation s...

Invesco 2025: AUM growth to $2.2T masks yield compression (23 bps) from passive shift. Margins stable at 33% adjusted despite cost pressures. Fair value $24-30; key risk is continued yield compression...

CPT delivered modest FY2025: same store NOI +0.3%, revenue +0.8%, with cost inflation 1.7%. Portfolio stable at 95% occupancy on .6B revenue base. Acquired 4 properties (+1,469 units), disposed 5 (-.9...

AIZ 10-K 2025 shows profitable growth: premiums +8.1% YoY, Global Housing EBITDA +27.9% driven by lender-placed expansion in hardened market. Balanced Lifestyle growth (+6.9%) with strong mobile momen...

GL fundamentals solid: premium growth 5%, net income +8%, life margins expanding to 45% driven by better mortality and assumption gains. Strong agent momentum, defensive market positioning. Key watch:...

Gartner's FY2025 10-K reveals a company hitting a growth wall: core Insights contract value grew only 1%, wallet retention collapsed (down 6-7 points), government spending evaporated (contract value d...

Quality AIDC leader with market dominance but FY2025 showed margin pressure (gross margin -30bps), EPS decline (-20%), and significant integration risk from $1.3B Elo acquisition. Tax rate headwind (1...

SJM 10-Q shows continued Hostess deterioration ($962M impairment, full goodwill write-off, brand reclassified to finite-lived) while core coffee/pet/spreads businesses remain fundamentally sound but f...

Stable 8% revenue grower with 85% retention and strong domain leadership. AI pivot via Airo and ANS shows management leaning into disruption rather than ignoring it. Key question is whether domains/we...

DOC FY2025 10-K: Merged with PRT (March 2024), now 689-property diversified healthcare REIT. .36B combined OM+Lab NOI, 34 senior housing communities planned for Janus Living IPO separation (H1 2026). ...

JKHY Q2 FY26 showed 7.9% revenue growth with strong operating leverage (+29% operating income). Cloud migration and digital/payments growth driving results. Acquired Victor for embedded payments expan...

PNW is a vertically integrated, regulated Arizona utility with stable earnings, strong asset base (Palo Verde nuclear), and clean energy transition underway. Load growth accelerating (5.3% YoY) from d...

SOLV is a newly spun healthcare company with diversified exposure to wound care, dental, and health IT. Strong heritage post-3M, but faces execution risks on independence, 3M dependency tail risks, an...

Leading independent DSP with strong CTV positioning and AI capabilities. 72% drawdown from highs creates attractive entry. Key risks: customer concentration, macro sensitivity, competition. Secular ta...

Medicaid reform legislation creates $432-480M annual headwind by 2032. Litigation tail risk material (Cumberland + Pinnacle). Geographic concentration elevated. Behavioral health segment more attracti...

SWK has successfully completed its .1B Global Cost Reduction Program and is positioned for margin recovery. However, 2025 earnings were pressured by tariff headwinds, customer concentration (HD/Lowe's...

Secular bull case intact. Data center supply-constrained TAM expansion + home standby 6.75% penetration whitespace. Tariff headwinds and OBBBA clean energy subsidy cliff create near-term margin pressu...

Brown-Forman H1 FY2026 results reflect challenging macro environment. Net sales down 4% YoY (flat organic), with volume pressures in core Jack Daniel's (down 6%) offset by New Mix strength (+28%) and ...

Market leader in clear aligners with solid 600M TAM but facing macro headwinds, competitive intensity, and execution challenges from consecutive restructuring. Recent innovations (Class II, 3D printin...

HRL Q1 FY2026: Foodservice pricing offset Retail collapse (-19.3% profit). Margin compression despite pricing signals cost inflation outpacing pass-through. Divestitures reduce portfolio. Conviction f...

ALLE FY2025 shows strong pricing (+3.1%) and margin expansion offsetting volume weakness (+1.0%). Electronics growth positive; tariff recovery working but unsustainable long-term. Residential market s...

HST: Luxury REIT with 76-hotel portfolio, 64% Marriott-managed, strong location diversification. Key risks: economic cyclicality, .1B debt with 20% floating, unionized labor, natural disaster exposure...

MAGIC driven 44.7% growth in Wizards segment with 46% margins. Consumer Products impairment signals structural challenges in physical toy business. Tariff headwinds and digital game execution risk are...

News Corp is a tale of two trends: Dow Jones professional information and digital real estate services firing on all cylinders with strong margins and pricing power, offset by Book Publishing stumblin...

High-quality grocery-anchored retail REIT. 565 shopping centers, 100.2M sq ft, 96.6% occupancy. FFO $1.76/share (+6.7% YoY), same-store NOI +3.0%. Strong balance sheet: 4.0% avg debt rate, 7.9yr matur...

First full year as Expand Energy post-Southwestern merger. Production nearly doubled to 2,622 Bcfe. Cash from ops $4.6B. Debt reduced $1.2B to ~$5B. Returned $865M to shareholders. Joined S&P 500. PV-...

DXCM FY25 10-K: 16% rev growth to 4.66B, strong margin expansion, 2B liquidity. G7 15 Day/Stelo on track. Key risks: 2028 Medicare bidding cliff, FDA warning letter. Fair value 88-95 vs 73 current.

Revenue +24% to $5.2B, Net Income +18% to $1.53B, EPS $14.25. Gross margin compressed 40.6% (vs 44.2%) due to higher US production costs, warehousing, and tariffs, offset by Section 45X credits. Cash ...

Quest FY2025 confirms defensive compounder thesis. $11B revenue stable, Advanced Dx $1B+ growing double-digits. FDA LDT rule vacated (favorable), PAMA delayed to 2026. 15th dividend increase. Stock ne...

Domino's delivered +3% U.S. comps and +1.9% intl comps ex-FX. Asset-light franchise model drives consistent royalty streams and strong FCF. Debt of .82B is material but manageable given recurring cash...

Post-merger Paramount faces high-stakes WBD acquisition attempt while integrating Paramount Global + Skydance. Streaming still unprofitable but improving. Linear TV declining but cash-generative. Sign...

GEN's organic growth weak (2-3% Cyber Safety), M&A-driven expansion via MoneyLion. Margin compression from TBS mix. Leverage elevated, refinancing risk 2027-28. Litigation tail risks material. Integra...

BEN: margin-accretive Q1 on AUM scale, but WAM scandal clouds growth outlook. Fixed income headwinds. Fair value ~$28-32 on base case, depends on litigation resolution.

MAS facing near-term margin pressure from China tariffs and softer home improvement demand, but maintains strong brands, market position, and cash generation. Margin recovery dependent on tariff mitig...

Revenue +2.4% YoY with 2.7% comp sales growth, driven by strong computing/mobile (+7.6%) and online (+3.5%). However, Best Buy Health impairment of M and restructuring charges of M in 9M reveal strate...

Everest's 2025 10-K reveals a mature reinsurer navigating social inflation headwinds and strategic refocusing. Gross written premiums of .7B support a strong balance sheet, but unfavorable reserve dev...

UDR is a quality, well-operated, diversified multifamily REIT with scale (165 properties, 55K homes) and strong operational metrics (19.4% turnover vs 34% industry). However, revenue growth is deceler...

Premium growth 8.9% to B, but new business -17.8%, retention 88.4% down from 90.4%. Exchange AM Best downgraded A+→A Sept 2025. Net income -6.8% despite premium growth. Investment income +22.4%. Thesi...

NWS bifurcated: Dow Jones quality growth (7-10%) offsetting declines in News Media and publishing headwinds. Valuation at 34x forward expensive. Recommendation depends on conviction re: Dow Jones dura...

AVY: Organic sales flat 2025 despite deflation headwinds, offset by >M restructuring savings. Tariff impact to apparel low-single-digit. Taylor Adhesives acquisition (flooring adhesives, M) expands hi...

CLX 10-Q shows revenue down 10% (ERP transition + lower consumption) with gross margin down 230 bps from cost inflation. EBIT declined 26% in 6M as volume deleverage overwhelmed cost actions. GOJO acq...

AKAM posted FY25 revenue .2B (+5%), with security booming (+10%, 53% of mix), cloud strong (+12%), delivery weak (-5%). Core moat is global edge network and security portfolio; competitive advantage c...

REG offers defensive grocery-anchored retail but faces refinancing headwinds and consumer spending risks in 2026-2027. Concentration in CA/FL adds climate/insurance pressure. Thesis: Hold pending macr...

Aptiv 10-K shows solid global scale but facing cyclical headwinds, separation costs, and execution risks. Wind River impairment (M) flags software strategy challenges. EDS spin-off creates transition ...

IEX 2025 10-K: 1% organic growth on price with volume weakness across FMT/FSDP offset partially by HST momentum (data center, semiconductors). Margins stable on productivity gains; interest expense +4...

TYL 2025: 9% revenue growth, SaaS now 68% mix (+18%), gross margin 46.5% (+270bps), ARR +11%, client attrition 2%. Quality compounder transitioning to mature phase. Recurring revenue base strong (87%)...

Kimco Realty: Fortress REIT with strategic portfolio in demographically-favored Sun Belt/coastal markets. Strong balance sheet (A-/A-/A3 unsecured), 7.9yr debt maturity, 91% unencumbered. RPT merger a...

PNR delivered 2.3% revenue growth via pricing (4%) despite 2.1% volume headwind. Gross margin +130bps and operating margin +80bps reflect pricing power and Transformation Program productivity. Pool (3...

Q1 systems revenue surged 36.7% but software declined 8.1%; cyber incident costs .5M in Q1 with ongoing legal risks; balance sheet fortress-like; valuation reasonable at 16.8x forward; conviction hing...

DECK growth remains healthy (9.8%) driven by HOKA momentum (16% growth) and international expansion (27% growth), but tariff headwinds and promotional activity compressed gross margin 50bps. UGG stabl...

Stabilized multifamily REIT with 301 communities (102.8k units). FY2025: steady acquisition/disposal activity, $272M development capex, 5,995 unit renovations achieving 7% rent lift. Portfolio well-po...

NDSN Q1: ATS accelerating 20.7% organic in semiconductor/electronics dispense. IPS margins pressured by mix. Strong operating leverage and cash generation. Riding AI/semi capex cycle. Valuation: 31x T...

INVH 2025 10-K: 86.2K-home SFR REIT with strong operational platform but facing inflation headwinds, regulatory uncertainty, and labor cost pressures. Scale and vertical integration provide moat. Rece...

GPC reported 3.5% sales growth on acquisitions + 0.9% comps, with 50bps gross margin expansion offset by 76bps SG&A deleverage. Announced separation into Global Automotive and Global Industrial (Q1 20...

CDW: 6.8% growth offset by margin compression and operational deleveraging. OI flat despite topline expansion. Hardware mix pressure and elevated transformation costs driving margin headwinds. Small b...

J executing transformation from conglomerate to pure-play consulting firm. Q1 revenue +12% (+16% PA, +12% I&AF). Gross margin compressed to 23.2% (project mix). Separation complete; PA Consulting acqu...

TRMB FY2025: Gross margin 69.1% (+400bps), operating margin 16.5% (+400bps) despite -3% total revenue. Subscription/services growth +2%, ARR +6% organic. AECO segment +10%, strong momentum. Divestitur...

COO is a dual-revenue business: CooperVision (contact lenses, 60% rev) and CooperSurgical (fertility/women's health, 40% rev). FY2025 shows 6-8% organic growth guided, forward P/E of 17x on .98-.02 EP...

CF 2025 10-K shows margin recovery to 38.4% (from 34.7%) driven by ammonia pricing bounce. Core strategic bet on decarbonization: Donaldsonville CCS online, Blue Point ATR ($4.25B total capex) under d...

Q1 FY26 revenues flat-ish (+2.5% YoY) at ,047.8M. Diagnostics down 1.3% (COVID normalization, assay pressures). Breast Health +1.8% but headwind from Brevera 9G needle stop-ship (4.7% of segment). GYN...

Insulet delivered 30.7% revenue growth (.7B) with 180 bps gross margin expansion (71.6%) driven by manufacturing efficiency, ASP/mix, and volume leverage. Net debt down 40% (.4B→M) via .5M convertible...

FY25 revenue +8% on military aircraft and aviation strength, offset by margin compression from MV-75 development mix and inflation. Backlog +5% to .8B with strong defense orders. Near-term margin head...

Viatris 2025 10-K shows .3B revenues with renewed base business momentum, but significant manufacturing headwinds (Indore FDA warning, Nashik fire) threaten near-term supply. Strategic EWSR underway w...

HII dominates U.S. nuclear shipbuilding (carriers, subs) with sole-source RCOH and amphibious assault capabilities. Strong backlog (B+ overage) backed by FY2026 B shipbuilding authorization. Key risks...

Revenue growth modest at 4.1% YoY despite 5.5% same-property NOI growth. Margin pressure evident. Portfolio concentrated West Coast (CA/WA) in tight supply-constrained markets. Development pipeline 54...

BALL executes well; volume and pricing offset raw cost inflation. Market share solid across regions. Tariff uncertainty and labor cost inflation are near-term risks. Fair value –37/sh; current fairly...

HPQ Q1 FY2026 shows revenue growth (+6.9%) offset by 1.4pp gross margin compression from commodity inflation and tariffs. Personal Systems strong (+11.1%) on PC refresh; Printing weak (-2.2%). Fiscal ...

WY navigating wood deflation while RE execution + climate solutions scaling drive diversification. Housing headwind near-term, but REIT structure + scale advantages intact. Housing recovery + climate ...

TKO 2025: UFC/WWE consolidated, IMG/On Location/PBR added, media rights renewing at higher valuations. International growth runway. Discretionary spending sensitivity and talent retention risks.

WST delivered solid 2025 results: 6.3% revenue growth, margin expansion +140bps to 35.9%, strong Proprietary segment (40.5% margin). GLP-1 tailwinds evident in self-injection devices. Restructuring on...

MKC facing margin pressure from inflation/tariffs despite pricing actions. Growth modest. Mexico acquisition provides growth lever but adds leverage. Fair value ~-53 assuming 17x forward P/E; current ...

SMCI Q2 revenue up 123% YoY to $12.68B on AI GPU server demand. Gross margin collapsed 550bp to 6.3% due to pricing/mix/tariffs. Inventory at $10.6B (+126% in 6M), AR at $11.0B (71.6% from one custome...

FTV post-separation 10-K shows resilient pricing (+2.2%) offsetting volume decline (-0.6%). Operating margin compressed 30bps to 17.3%. Key concern: AHS segment weakening due to healthcare policy head...

Alliant Energy: regulated Midwest utility with 1M+ customers. Modest 9.6% electric revenue growth. IPL facing rate moratorium through 2029 limiting near-term recovery. Renewable generation buildout on...

2025 marked major structural changes: Houston refinery shutdown (GHG reduction +3M metric tons Scope 1&2), European divestiture announced (4 sites, 25% O&P-EAI capacity), PO JV permanent closure. Q3 s...

LII faces volume headwinds in residential HVAC (down 17%) reflecting housing market weakness, but pricing discipline (10% in HCS, 8% in BCS) and commercial resilience (5% growth) provide offset. Gross...

PTC delivered impressive Q1 results: revenue +21% YoY to M, ARR +13% to .49B, operating margin expanded 1,180 bps to 32%, and net income +102% to M. License revenue surged 56% driven by longer, higher...

ALB placing majority of lithium capacity into care & maintenance as 85-95% lithium price collapse forces existential restructuring. Divesting refining solutions to improve margins. Still exposed to Ch...

ZBH facing margin compression (earnings -22% vs revenue +7.2%) driven by one-time charges, tariffs, and structural reimbursement headwinds. US sales force transformation creates near-term disruption r...

Evergy delivering steady earnings with rate case victories supporting revenue growth. Dividend sustainability remains strong. Key risks: regulatory headwinds, capex intensity, rising interest rates on...

INCY faces 2028 JAKAFI patent cliff but strong new product launches (MONJUVI FL, ZYNYZ SCAC, NIKTIMVO) and advanced pipeline (povorcitinib, INCA033989, KRASG12D inhibitors) offer growth transition. Yv...

MRNA FY25: COVID decline offset by pipeline optionality. intismeran melanoma data strong; flu launch critical 2026-2027. Fair value -45B on probability-weighted pipeline; current B valuation reflects ...

NTAP Q3 shows solid 4% YoY growth and 12% net income growth, but Hybrid Cloud segment margins compressed 110 bps YoY due to component cost inflation. Core business is resilient (70% gross margins, str...

CSGP acquiring its way into AI-first, multi-segment portfolio (CRE, residential, 3D, lease mgmt). Large debt burden from M&A; integration risk high. Homes.com and Matterport are bets on emerging trend...

Snap-on posted modest growth in FY2025 (+0.8%) with tariff headwinds compressing margins. Franchise model remains resilient with strong brand, but growth deceleration and competitive pressures evident...

EXPD 10-K shows bifurcated performance: airfreight strength (+9%) and customs brokerage surge (+13%) offset by ocean freight catastrophe (-11%, rates down 41-42% in Q4). Supreme Court tariff ruling Fe...

Major transformation year completed: Qnity spin-off done, Aramids sale pending Q1 2026. Focus now pure-play healthcare/water + industrials. PFAS/litigation overhang remains material. Healthcare segmen...

IFF restructuring post-Frutarom/N&B integration with major divestitures, .1B impairment, antitrust litigation overhang, debt reduction focus via dividend cut.

TROW reported strong .78T AUM (+10.5% YoY) driven by .7B net market appreciation, but net cash outflows of .9B pressure revenues. Investment advisory fees grew only 3.2% despite 7.4% average AUM growt...

PFG: stable diversified insurer, fair valuation, holds thesis but requires patience. Benefits from secular tailwinds in retirement; risks center on rates/equity volatility. 6/10 conviction — hold curr...

Americas collapsing (-5% comps), tariffs will reduce FY2025 OI ~M, CEO transition underway. China growing strong (+24% comps) but can't fully offset. Margin compression real. Downside risk elevated.

PKG: 3rd largest North American containerboard producer. FY2025 EBITDA ex-special items grew 13.7% to ,862M on pricing power (+/ton March 2026), though integration of .8B Greif acquisition just begun....

NVR FY2025: Revenues flat, net income -20%, margins compressed 240bps to 21.2%. Affordability crisis driving 17% cancellation rate and -10% order declines. South East segment in severe distress (margi...

SBAC acquired 7K+ towers via Millicom but faces $168-171M churn headwinds in 2026 from EchoStar, Sprint, and Oi. Impairments surged 94%. Interest rates +17% weighing on $13B debt. Brazil currency & ma...

First Solar 10-K FY2025 shows structural demand tailwinds from IRA and data center growth, offset by near-term execution risks (Series 7 quality, tariffs) and policy uncertainty post-2026. Differentia...

GPN pivots to pure-play merchant acquirer via Worldpay deal. Strong market position + global reach, but integration risk elevated. Chargeback exposure increased materially. Debt service drag on FCF ne...

VeriSign 2025: resilient cash machine with inflecting domain base growth, modest near-term upside, material 5Y regulatory renewal risk.

BR showing organic momentum in recurring revenue (7-9% growth organic) with strong GTO segment acceleration (15.4% pre-tax margins) but ICS margin compression from postage/distribution inflation. Digi...

Strong operational execution: 490bp adjusted operating margin expansion, net income +26.1%, operating cash flow +79.6%. Revenue headwinds (divestiture, ocean compression, tariffs) largely expected and...

RL Q3 FY26 shows classic luxury resilience with double-digit comps, margin expansion, and AUR-driven growth across all segments. Digital +15% 9M demonstrates direct-to-consumer traction. Inventory +21...

DOW reported B in sales for 2025 with three operating segments. FY2025 saw significant impairments (M goodwill in Polyurethanes, M asset impairment in Latin America) signaling regional challenges. Com...

Centene faces convergence of structural headwinds: Medicaid member acuity rising, Marketplace risk pool deteriorating, Medicare pricing inadequate, balance sheet impaired. Corrective pricing actions u...

JBHT navigated flat revenues (-0.7% to .0B) with strong expense discipline, lifting operating income +4.1% and operating ratio to 92.8%. Segments mixed: JBI stable, DCS steady, ICS turnaround (loss na...

AMCR post-Berry integration on track but facing macro headwinds and execution risk. Organic volumes declining 3%, synergies M over 3 years, leverage manageable at 3.2x. Hold at .43; wait for -45 entry...

Leidos is a pure-play government services provider with strong geopolitical tailwinds and a diversified contract mix. Core thesis: secular growth in defense/national security spending + AI/space moder...

NiSource Inc. (NI) is a regulated utility with ~3.8M customers in gas distribution and electric operations. Core business offers stable dividends and regulatory moats, but company is pursuing transfor...

Loews exhibits a diversified conglomerate structure: CNA (81% revenue) stabilizing post-loss reserve actions; Boardwalk (13% revenue) benefiting from LNG/power demand with .3B capex pipeline; Hotels (...

KeyCorp 10-K shows a classic late-cycle regional bank—exposed to CRE stress, NIM compression, and intensifying competition. Limited upside; downside risks elevated.

Q1 FY2026 operating margin collapse to 2.1% driven by Beef segment losses (M), structural cattle cost inflation, and M antitrust settlement charges. Fair value dependent on Beef margin recovery to 2-3...

HUM faces material headwinds from 2025 Star Rating decline (lawsuit outcome pending Fifth Circuit appeal), expanding RADV audit exposure for PY2018-2024, and Florida Medicare concentration (14% of rev...

Recurring B2B payments platform with strong network moats and tech platform, but facing macro headwinds (FX, fuel prices), regulatory expansion costs, and intense competition. Recent M&A signals growt...

Portfolio-focused packaging pure-play post-DS Smith acquisition. Major EMEA separation catalyst (late 2026/early 2027). Divested non-core Cellulose Fibers (.5B). Restructuring initiatives ongoing. Pos...

Strong production growth (+15% volumes from acquisitions and organic ramp) offset by significant margin deterioration. Cost/Boe inflation (+37% YoY) and 14% decline in oil prices compressed profitabil...

Bunge's Viterra integration is the key investment thesis. High leverage is manageable if synergies realized; cyclical commodity exposure is elevated given FY2025 strength.

Quest reported stable FY2025 with Advanced Diagnostics and operational efficiency offsetting reimbursement headwinds. Strong market position, B+ Advanced Dx revenue on double-digit growth, AI/automati...

Regulated Michigan utility with 6.8M customer base executing clean energy transition. Revenue .5B, margin profile stable, significant debt load typical for utilities. Moat: regional monopoly. Key risk...

FOXA Q2: Revenue +3%, net income -30% from investment losses and cost pressures. Cable strong (EBITDA +6%), TV weak (EBITDA -6%) from sports inflation. MVPD decline offset by rate hikes. FOX One launc...

FY2025 strong results: 7.2% revenue growth, 4.4% organic, both segments expanding margins. Margin expansion driven by operational leverage and mix improvement (specialty/CDx growth). Strategic positio...

GIS trading volume decline accelerating into negative price mix territory. Organic net sales -1% YoY with organic price/mix at -2%, suggesting pricing power waning and consumers pulling back. Operatin...

FOX Q2 shows 2-3% revenue growth but EBITDA declining due to sports rights inflation and digital investment losses. Cable segment (44%) holding up with strong distribution pricing; TV segment (56%) ma...

FY2025 revenue .5B (+6.0% GAAP, +4.7% core). Operating margins flat at 23.2%. Recurring revenue 61%. WQ segment +5.9% sales, +100bps margin. PQI +6.2% sales, -50bps margin. Strong cash generation .077...

Well-capitalized regional bank with solid Southeast franchise but facing FDIC assessment headwind, CRE concerns, and intense competition. Valuation at 1.26x book appears full given risk profile.

BRO closed massive Accession acquisition (RSC Topco) in Q3 2025 for .5B+ debt, increasing leverage significantly. FY2025 shows 22.5% total commissions growth but organic growth decelerated to just 2.8...

WSM executes well in Q3 amid tariff escalation and macro uncertainty. Margin defense working through pricing + sourcing, retail channel thriving, but housing TAM weak. Tariff risk material but current...

Smurfit Westrock achieved M integration synergies by end 2025 post-Combination. FY2025 marked cyclical trough with Q4 mill downtime signaling overcapacity. Strong vertically integrated system offset b...

STE: Broad-based 9% revenue growth (all segments positive) but Q3 gross margin down 70 bps due to tariffs/inflation despite pricing wins. AST performing best (45% margins); Healthcare/Life Sciences fa...

EQR: Diversified, operator-led multifamily REIT with premium coastal market exposure, strong occupancy, active development pipeline, and macro tailwinds from housing supply/demand imbalance. Key risks...

DRI delivered solid sales growth (+8.9% YoY, +4.5% same-restaurant) driven by Olive Garden and strong pricing. However, margin profile deteriorated: LongHorn Steakhouse pricing 320bps BELOW inflation ...

Credit quality improving (NCO -66bps to 5.65%, delinquencies -21bps), but volume flat, active accounts declining. Retailer share +17.6% to $4.0B becoming material. Earnings +1.5% masks efficiency dete...

AVB trading at ~$115-120. Strong operator in tight rental markets but facing regulatory headwinds (rent control, antitrust), rising debt costs, and sector-wide normalization. Conviction: 5/10 due to m...

CHD executing strategic portfolio shift toward faster-growing value/premium lines (Touchland, BATISTE, HERO, THERABREATH). Exit of slower-growth SKUs (Flawless, VMS) de-risks margin profile. Strong br...

Southwest Airlines filed amended 2025 10-K (exhibit correction only). Faces 2026 operating headwinds: labor cost inflation, capacity discipline across industry, consumer health uncertainty. Domestic l...

EFX cloud transformation progressing; data moat intact. Mortgage headwind, CFPB scrutiny, execution risk. Valuation fair at current levels; execution > multiple expansion.

Fortress balance sheet + agency channel moat, but 2025 personal lines losses and equity portfolio concentration present downside risks. Hold pending cat loss severity assessment.

Solid Q3 fundamentals with +11% YTD revenue growth and stable-to-expanding margins despite tariff headwinds. Management execution on pricing and cost mitigation is credible but near-term uncertainty r...

CFG: B asset regional bank with B deposits and strong capital position. 2-segment structure (Consumer/Commercial). Consumer mortgages pressured by rates; Commercial more stable. Key risks: CRE exposur...

Largest US independent NG producer post-CHK-SWN merger. Strong FY2025 execution: production +91%, price +52%, debt -.2B, reserves +91%. Reserve base PV-10 .4B vs implied market cap suggests meaningful...

PHM reports 2025 with revenues down 3%, earnings down 28%. Gross margins compressed to 26.3% from 28.9% on elevated incentives and higher land costs. Order trends weak, backlog down 19%. Company expli...

FY2025 solid but decelerating growth (room nights +8% vs 9%). Advertising surge (+19%) and trivago turnaround (+33%) offset air pressure. Platform consolidation + One Key loyalty + AI gains are positi...

Newly spun Qnity is a critical materials supplier riding AI/HPC supercycle, but faces post-IPO integration, heavy debt (4.1B), customer concentration (Samsung/TSMC = 19% combined), China exposure (33%...

AWK: Largest US water utility with .7B regulated revenue, 3.6M customers, 24 states. 10-yr -48B capex plan driven by aging pipes + PFAS/lead compliance. Regulatory environment favorable for rate recov...

FIS integrating Issuer Solutions acquisition to enhance platform capabilities; leverage elevated post-acquisition; core banking and capital markets businesses stable; modernization execution critical.

Restructuring-driven margin expansion offset by AI TAM and ISG decline risks. SiC/GaN moats strong, but valuation already reflects recovery benefits. Fair value -52; conviction 6/10.

FY2025: .3B revenue (+9.3% normalized), 14.6% normalized operating margin. IPG merger closed Nov 25, driving integration charges of .1B that masked healthy underlying performance. Post-merger combined...

Devon Energy: Large-cap independent with fortress balance sheet, disciplined capital, and scale from Grayson acquisition. Merger with Coterra pending Q2 2026 creates near-term uncertainty but unlocks ...

Northern Trust 2025 10-K shows stable positioning across Asset Servicing (.4T AUC/A) and Wealth Management (.2B AUM). Strong capital ratios (CET1 12.6%), compliant with liquidity standards, and focuse...

Hubbell (HUBB) FY25 execution solid on pricing and productivity (+140bps gross margin expansion), but tariff pressure mounting. Utility Solutions organic growth +1.1% with volume headwinds despite str...

Best-in-class specialty P&C insurer with 90.7% combined ratio, 41% insider ownership, and 60 niche businesses. Premium growth decelerating (6.2% vs 9.3%), heavy analyst downgrades. P/B 2.79x after 147...

TSCO FY25: Sales +4.3% to $15.5B, comps +1.2%. Gross margin +16bps to 36.4% on cost management. Operating margin -41bps to 9.5% from SG&A deleverage. Net income flat at $1.10B. Strong FCF $1.64B. Conc...

Q3 FY2026: Beer resilient (-1% rev) but depletions weak (-3%). Tariffs costing $70M FY26. W&S restructured to premium-only. Consumer demand soft. Debt elevated at $10.7B.

Sales flat YoY (.9B), but operating leverage improved. EPS up 21% (.92) driven by lower restructuring charges, pricing gains, and productivity. Aerospace double-digit growth offsets auto refinish decl...

MTD 2025: Revenue +4% USD but margin compression from tariffs (-50bps) and mix. Service strong. China soft post-COVID normalization. Management expects tariff offset in 2026 but visibility low. Pricin...

Biogen's 2025 10-K reveals a company in strategic transition. MS franchise under heavy biosimilar pressure (TECFIDERA generics, TYSABRI biosimilar). Rare disease growth (SPINRAZA, SKYCLARYS, QALSODY) ...

LEN FY25: volumes flat-to-up (+2.9% YoY), ASP down 7.5% YoY to K. Earnings down 46% to .1B. Margins compressed to 15-16% guidance for Q1 FY26. Land-light model executing well (98% optioned). Affordabi...

JBL strong AI momentum with Intelligent Infrastructure +54%. Hanley acquisition strategically sound. Margins stable, working capital efficient. Risk: customer concentration and capex cycle dependency....

CNP executing strategic portfolio optimization: divesting low-margin gas assets (.2B LAMS sold, .6B CEOH sale announced), investing in transmission hardening (.75B SRP) and generation diversification ...

FY2025 record revenues of $16.99B (+16.6%), gross margin 19.3% (+30bps), op margin 10.1% (includes $144.9M UK gain). Organic growth ~7.9%, Electrical segment +52% (incl. $1.11B Miller Electric). AI/da...

Core EPS 2025=6.55, 2026E=5.90-6.20 (muted), 2027E=6.25-6.65. Rate base 47.6B to 67.9B by 2030 (5.5% CAGR). Eaton Fire: 1.1B recorded, 1B recovered, net 9M after-tax shareholder impact. Self-insurance...

STLD posted record steel shipments (+9%) but consolidated operating income fell 24% due to metal spread compression in core steel and fabrication segments. Aluminum mill ramping, generating losses but...

Q1 FY26 blowout: revenue +15%, non-GAAP EPS +15%, OCF +26%. VAS +32% becoming new engine. MDL settlement 87% complete. $21.1B buyback. Thesis fully confirmed.

ES 10-K FY2025 shows solid regulated utility with .2B in electric distribution revenue (CL&P CT), multiple rate mechanisms, but faces headwinds from ESI phase-out in CT, PBR implementation uncertainty...

FY2026: $215.9B revenue (+65% YoY). Data Center $193.7B (+68%), 90% of total. Q4 GM 75.0% (recovering). Q1 FY2027 guided $78B. Net income ~$120B, OCF ~$103B. $40.4B buybacks + new $60B auth. China DC ...

Azure +39-40% confirms AI demand. Commercial RPO +110% to 625B signals enterprise AI cloud scale commitments. 47% operating margin with 17-18% revenue growth. CapEx surge (49.3B H1) compressed FCF but...

FY2025: Revenue $200.97B (+22%), FoA op income $102.5B (52% margin), RL loss -$19.2B. Net income $60.5B depressed by $15.93B OBBBA tax charge. 2026 capex guided $115-135B (vs $72B). 2026 ETR guided 13...

DXCM 10-K 2025: G7 15Day clinical leadership + Stelo OTC TAM expansion offset by 2028 Medicare competitive bidding risk and March 2025 FDA warning letter. Bull case: superior tech, ecosystem lock-in, ...

FY2025 adj EPS $14.69 (-3.6% YoY). Core comparable sales +0.3% (flat). SRS+GMS acquisitions add revenue but compress margins. Adjusted operating margin 13.1% (down from 13.8%). FY2026 guided flat-to-+...

FY2025: 416.2B revenue (+6%), EPS 7.46 (+23%). Services 109.2B (+14%) at 75.4% gross margin drives total GM expansion to 46.9%. iPhone 209.6B (+4%, Pro-mix driven). China 64.4B (-4%) -- 2nd consecutiv...

HPE transformed from pure-play hardware to platform company through Juniper acquisition. Networking now core to AI value chain. GreenLake consumption model and AI infrastructure position well if integ...

EIX 2025 10-K shows pivotal inflection: wildfire settlement framework unlocks $3.6B regulatory recovery authorization, SB 254 prudency standard removes Eaton Fire tail risk, normalized $2.5B core earn...

Verisk delivered 6.6% revenue growth in FY2025 (.07B), with underwriting +7.7% and claims +4.1%. EBITDA margin stable at 54.3% despite pricing of new debt. Insurance remains 70% of revenue (primarily ...

KHC facing structural margin pressure from tariff-driven cost inflation, limited pricing power, and negative operating leverage from platform concentration. .3B impairment in 2025 signals overpaid M&A...

WTW is executing well on margin accretion strategy while scaling advisory platform. HWC declining to 55% of revenue (from 60% in 2023) as Risk & Broking strengthens, indicating portfolio pivot toward ...

Stable regulated utility with 3 regional franchises. Rate base growth 3-5% annually. Capital-intensive with strong moat. Dividend focus, modest growth. Primary risks: regulatory execution and energy t...

ROL 2025 strong fundamentals: 6.9% organic growth, 20% adj operating margin, M FCF, 0.9x leverage. Q4 weather headwind noted. 2026 guide 7-8% organic growth. Solid execution on acquisition strategy.

FE is a B+ market cap regulated utility with 6M+ customers, .3B distribution rate base, and .4B transmission rate base. Strong earnings foundation from cost-based regulation, but facing FERC ROE headw...

Solid revenue growth (+5.6% NR YoY) offset by earnings decline (-6.2%) driven by comp inflation and expense pressure. Deposit and loan franchises healthy. CRE credit risk manageable. Capital deploymen...

Halliburton facing demand headwinds and margin compression in 2025. Revenue down 3%, but operating income fell 41% as C&P and D&E segments deleverage with lower activity. 2026 outlook cautiously expec...

Video decline offset by Internet/mobile growth. Fiber network evolution on track. Large M&A deals pending with elevated debt but strategic rationale clear.

IQVIA: Global leader in clinical research and healthcare intelligence with 1.2B patient records and 100+ country presence. Serves 335B addressable market across three segments. Competitive moat from p...

ULTA delivered +6.3% Q3 comp sales and +5.2% YTD, driven by ticket +3.8% and transactions +2.4%. Gross margin expanded 70bps to 40.4% on shrink reduction and pricing power. However, SG&A deleverage (-...

DTE Energy (B market cap) reported solid FY2025 fundamentals with disciplined balance sheet. Electric segment driving growth via 100% clean energy mandate (by 2040) and significant capex. Gas utility ...

ATO Q1 FY2026: Strong rate execution (+$122.5M approved increases) and capital spending ramp ($1.0B quarterly) drive 14% revenue growth. Regulated utility model with minimal execution risk. Valuation ...

Diversified industrial manufacturer executing operational excellence playbook; margin expansion offsetting near-term growth headwinds. Strong M&A track record, fortress balance sheet, and secular posi...

CTSH delivered solid operational execution in FY2025 with 7% organic revenue growth, 140bps margin expansion, and improving attrition. Core segments (HS, FS) strong; CMT weakness concerning. Tax charg...

AEE is a $31B regulated utility with dual-state operations (MO & IL). Recent rate cases supportive. Capital program focused on grid modernization aligns with infrastructure spending macro theme. Predi...

Waters completes .8B BD Biosciences acquisition (Feb 2026). Transforms from pure analytical instruments to diversified life sciences platform. B new debt requires Q1 2026 refinancing. M revenue + M co...

CBOE executing strategic realignment to focus on core derivatives and U.S. equities franchises. Business heavily dependent (68% of revenues) on exclusive S&P 500 and proprietary VIX licenses—a major v...

Strong B revenue (+5.5% YoY) with structural water tailwinds (aging infra, sustainability). Key concern: backlog down 9% to .6B suggests demand softening or project timing shifts. Ongoing Evoqua integ...

Coach accelerating with 25%+ growth and 39.5% margins, but Kate Spade collapse (op margin 4.5% in Q2) masks underlying weakness. Tariffs are 190 bps headwind in Q2. Debt manageable post-Capri terminat...

TDY FY2025: +7.9% revenue growth, +140bp margin expansion. A&DE surged 36% via acquisitions but margins compressed. Core segments (DI, Instr) stable but organic growth slowing. Engineered Systems decl...

IRM delivered strong FY2025 with 12.2% revenue growth to .9B. Data center segment surging (+33% YoY) with 97% utilization and 852MW pipeline. RIM stable with improving margins. AFFO grew 14.6% to .17/...

VICI: High-quality scale REIT (100% occupied, B revenues, 93 assets) facing acute Caesars/MGM concentration (74% rent), Las Vegas geographic concentration (49%), and emerging competitive threats from ...

Record revenues, margin expansion, AI/data center driven. Industrial services weak. Valuation elevated but thesis intact if capex cycle continues.

Revenue -6% to .3B. Gross margin compression in Ag Services & Oilseeds (77% of sales) due to global supply glut, trade uncertainty, biofuel policy deferral. Carbohydrate Solutions weighed by lower eth...

MTB: .5B Northeast regional bank facing 3-5yr NIM compression from Fed plateau. Strong deposit franchise (78% core), but elevated CRE criticized loans and securities losses. Capital adequate but const...

FICO: Fortress Scores moat driving +29% B2B growth on housing recovery, but Software bifurcated (Platform +33%, Non-platform -8%) and leverage elevated at 7.0x. Antitrust litigation tail risk. Fair va...

Extra Space's 2025 results show modest revenue growth (+3.3% property rental) masking deteriorating fundamentals. Same-store occupancy fell 70bps to 92.6% YE, driving NOI decline of -1.7% despite acqu...

Paychex reports strong Q2 with 17% service revenue growth (7% organic + Paycor contribution), though reported net income down 4% due to .9M acquisition costs. Adjusted metrics beat (+11% adj. NI, +21%...

FISV: Stable recurring revenue fortress with debt/execution headwinds. 80% non-discretionary processing/services, strong cash generation, but transformation risk and elevated leverage require caution....

HBAN completed Cadence acquisition on Feb 1, 2026, becoming a B+ regional bank. While capital-strong and strategically positioned, company faces significant integration execution risk, Category III re...

PRU executed solid FY2025 amid stable interest rate environment. Core themes: (1) Pension Risk Transfer segment continued strong momentum with B+ in assets under administration, offset liabilities wit...

DG delivering margin expansion (100+ bps) driven by shrink improvement + markup power despite consumer pressure. SSS of 2.5% suggests lower-income consumer resilient but pressured. Capital allocation ...

Agilent's reorganized structure positions it as an integrated biopharma diagnostics player with strong LCMS/cell analysis platforms and CDMO capabilities, paired with high-margin recurring CrossLab se...

UAL executing United Next growth plan with fleet modernization and hub expansion, but facing severe labor cost inflation (new contracts driving material wage increases), operational constraints at key...

WDAY Q3 shows solid subscription reacceleration (15% YoY), margin expansion (operating margin +310bps to 10.7%), and strong financial position (.8B liquidity, .56B FCF). Strategic acquisitions (Parado...

State Street 10-K shows mature custodian with .8T AUC/A but facing structural NII headwinds and pricing pressure. Capital ratios solid, but growth limited. Fair value -42 range with hold recommendatio...

OTIS 2025: Service +5% organic growth offsetting New Equipment collapse (-7%, China >-20%) by leveraging expanding Service margins (25.1% vs 24.6% prior year). Operating margin still expanded to 14.8%...

Texas Pacific Land Corp 10-K analysis: M revenue (+13% YoY), M net income (+6% YoY), exceptional 62% net margins. Royalty production grew 30% to 34.6 MBoe/d. Water business (30% of revenue) accelerati...

Arch Capital demonstrates strong capital generation (22.7% book value growth), disciplined underwriting across specialty lines, and strategic geographic/product diversification. Recent acquisitions (B...

KVUE FY2025: Largest pure-play consumer health company emerging from J&J separation and entering K-C merger. Strong brand moat but faces retail consolidation, product liability, and regulatory headwin...

ARES delivered exceptional AUM growth to .5B (21% CAGR over 10 years), deployed .8B in 2025, and raised .2B in commitments. Diversified platform across Credit (.9B), Real Assets (.1B), Secondaries (.1...

CPRT margins expanding faster than revenue growth, reflecting operational excellence and capital discipline. Revenue flatness is cyclical (hurricane comps) not secular. Fair-valued at current levels w...

Kimberly-Clark's 2025 10-K shows transformation in progress. Organic growth of 1.7% is solid but masked by divestitures and FX headwinds. The planned Kenvue acquisition (consumer health) is transforma...

Ingersoll Rand faces organic revenue headwinds and margin compression in 2025 despite successful acquisition integration. Negative organic growth (-1.3%), gross margin contraction (20 bps), and Adjust...

Strong Q2 with 11% revenue growth, 320 bps gross margin expansion to 61.8%, and improving litigation profile. Secular tailwinds in home-based respiratory care intact. Patent risk abating (NYU dismisse...

ROP executed well in FY2025 with 5.4% organic growth and $2.65B M&A (CentralReach, Subsplash) in AI-enabled verticals. Operating margins stable at 28%, backlog +10%. However, leverage elevated at 32% ...

LYV posted record 2025 with .2B revenue (+9%) and .37B AOI (+10%), driven by stadium touring, international expansion, and deferred revenue inflection (+21%). Concerts AOI surged 30% on fan growth (15...

Regulated utility (Wisconsin, Illinois, Michigan electric & gas) with B market cap. Strong moat through franchises and 60% ATC transmission stake. Stable 92.3% retail revenue base but modest 1.6% grow...

WEC Energy Group (WEC) is a diversified B market cap regulated utility with 60% stake in transmission operator ATC. 2025 fundamentals show modest growth from weather-normalized electric sales (targeti...

Integrated Appalachian producer with strong 2025 fundamentals. Reserves +7% to 28 Tcfe with Marcellus concentration (93%), proven low-cost model, and significant undeveloped inventory (30+ year runway...

Macao gaming market growth accelerating (9.1% YoY, 14.7% visitor growth) with LVS well-positioned in mass market. Singapore generates 56% EBITDA with duopoly advantage through 2030. MBS Expansion (B t...

GEHC FY2025: Solid healthcare recovery thesis undermined by 2025 tariff materiality. Company explicitly warned tariffs materially hurt profitability; mitigation insufficient. Imaging capex cycle impro...

NRG Energy completed LSP Portfolio acquisition (13 GW nat gas), strengthening vertical integration thesis. Texas development projects (1.5 GW) supported by TEF subsidies. Retail customer base stable; ...

Block FY2025 10-K shows mature fintech platform with 3 revenue pillars (Commerce Enablement, Financial Solutions, Bitcoin) generating .4B gross profit. Recent >40% workforce reduction announced (Feb 2...

CCI 2025 10-K shows core tower business under pressure from T-Mobile consolidation headwinds and DISH default (M revenue impact in 2026). Fiber divesture for .5B (closing H1 2026) allows debt paydown,...

TTWO revenue +23% YoY to .98B (9M), net loss cut 68% to -.7M. Gross margin +200bps to 57.7%, driven by software amortization timing and Borderlands 4 success. GTA VI launching Nov 2026, major catalyst...

Hartford's FY2025 10-K demonstrates strong earnings power with 19.4% ROE, disciplined underwriting across P&C portfolio, and 8% organic growth in Business Insurance. Thesis: market leader in middle-ma...

DDOG FY2025 shows 27.6% revenue growth (.43B), down from 26% prior year. Core thesis intact (unified observability platform, strong NRR) but facing growth deceleration, customer concentration risk in ...

Q2 FY2026 shows margin recovery from PRGP + Mainland China strength (+11%), but makeup segment stalling (-1% CC) and tariff headwinds create offset. FY2025 impairments (M) create tough YoY comp, but u...

Inventory correction underway post-destocking cycle. Margin recovery (59.6% Q3) validates product positioning in AI/data center. Debt trajectory manageable but tax liabilities uncertain. Hold pending ...

NUE volumes stabilizing with 7% ton growth; margin compression in products segment offset by strong mills performance; balance sheet fortress; macro headwinds from overcapacity and Chinese export surg...

Ed 2025 10-K shows stable regulated utility operations with strong rate base growth trajectory. Electric and gas transmission segments performing well with favorable regulatory support. Clean Energy B...

MLM: Aggregates consolidator executing portfolio optimization toward pure-play aggregates focus. Strong reserve base and geographic diversification in growth markets, but cyclical exposure and pricing...

VTR FY2025 10-K: .4B NOI portfolio anchored in senior housing (49%). Brookdale NNN exit underway. Atria concentration at 17.7% of SHOP. Medicaid/labor cost pressures emerging; wage inflation (CA SB-52...

Aggregates leader capitalizing on infrastructure tailwinds with pricing power, margin expansion from 3-yr cash profit/ton +20%, and disciplined execution. Fair value $240-250/share (13x forward EBITDA...

eBay FY2025: B GMV marketplace with solid fundamentals (135M buyers, 30yr trust moat) offset by tariff headwinds, AI search disruption risk, EU regulatory burden, and margin pressure from fraud/protec...

eBay 2025: Resilient core (GMV B, 135M buyers) but pressured by tariffs, FX headwinds, and regulatory costs. AI rollout ongoing. Takerate compression near-term risk; long-term upside if execution on s...

KDP 2025 fundamentals sound (revenue +8%, EBITDA margins holding via cost mgmt) but capital structure deteriorating. JDE Peet's acquisition + separation creates execution overhang. Appliance weakness ...

Regulated utility undergoing B+ decade-long capex cycle to harden aging grid and integrate renewables while managing legacy wildfire costs. Rate recovery depends on CPUC acceptance of capex and execut...

ODFL demonstrates strong yield discipline (+3.9% LTL rev/cwt) and operational excellence (99% on-time) amid macro volume weakness (-9.1% tonnage). Operating ratio deterioration (73.4%→75.2%) reflects ...

DAL delivered solid 2025 but main cabin demand weak. Premium products (+7%) and loyalty growth (+10%) driving revenue, but 8% wage inflation pressuring margins. Operating income flat YoY despite 3% re...

PSEG is a well-capitalized regulated utility holding company with diversified revenue streams: PSE&G distribution (NJ regulated T&D), PSEG Power (nuclear generation + gas supply), and LIPA operating s...

MSCI: Scale SaaS index/analytics provider with 57% recurring Index revenue, 22.8% Analytics, 11.3% Sustainability. Strong market position but vulnerable to client self-sufficiency, BlackRock concentra...

HOLD target | conviction 6/10. TPV deceleration + transaction decline offset by crypto upside. Fairly valued; lacks compelling catalysts for significant near-term upside. Regulatory moats defensible ...

AIG positioned as core insurer with improving fundamentals, though facing renewal headwinds in near term. Core insurance franchises sound, capital adequacy healthy. Macro exposure to CRE and rate cycl...

Axon 2025 10-K shows strong SaaS growth (.3B ARR), strategic M&A (Carbyne into NG911), and sustained law enforcement dominance. Material weakness in revenue controls remains unresolved; regulatory ris...

CCL delivered exceptional FY2025 results: record 26.6B revenue, 4.5B operating income, 105 percent occupancy, 2.76B net income. Balance sheet strengthened with debt down 10B+ from peak, investment-gra...

Market leader executing well on cost but facing structural headwinds. Growth is 70% inflation, 30% volume. Expense discipline weakening. Valuation (24.6x) unjustified at 3% top-line growth.

AMP: Widow-maker risk from rate sensitivity and market exposure. Fair execution but challenged growth environment. 6/10 conviction.

CBRE delivered 13.4% revenue growth to .6B and 19.5% net income growth to .2B in 2025. The commercial real estate recovery is firmly underway: leasing/sales activity rebounded sharply, capital markets...

FITB trading at fair value () with deteriorating credit trends and NIM compression offsetting diversified revenue. 2026 set for earnings pressure as CRE stress accelerates and rate environment stabili...

WAB delivered solid 7.5% organic-plus-acquisitions growth in FY2025 with margin expansion. Record .4B backlog (22% of sales) supported by Kazakhstan mega-order (.2B) and strong NA locomotive demand. T...

KR Q3 2025: .6B fulfillment impairment masks strong 7% adjusted earnings growth, 3.1% identical sales, and intact margin expansion. Pivoting to capital-light eCommerce model. Reasonable valuation at 1...

ROK momentum intact in Q1 FY2026: +12% reported, +10% organic sales. Software & Control (31.2% margin) and Intelligent Devices (+18% organic) driving growth despite weak PMI. Margin expansion 290bps t...

DHI Q1 FY2026: Pre-tax income -28% YoY to M; home sales margin compressed 230 bps to 20.4%. Affordability crisis driving incentive escalation and price declines despite stable order volume. Earnings p...

Mature franchisor with strong digital transformation (60% sales from digital), but facing macro headwinds (commodity inflation, labor cost pressures, consumer discretionary weakness), China exposure v...

Coinbase 10-K shows platform diversification beyond spot trading into Everything Exchange (equities, futures, prediction markets), staking infrastructure (.7B AUM), and stablecoin revenue. Regulatory ...

MetLife's 2025 earnings decelerate as higher bond yields reduce VA liabilities (favorable) but pressure fixed annuity spreads. Core U.S. insurance stable; Asia remains drag. Dividend sustainable but R...

HSY FY2025 margin compression severe (1,380bp gross, 1,360bp operating) driven by cocoa/tariff costs (.5B+ headwind) offset by 6% pricing. Commodity hedging losses (M) add to pain. International segme...

Regulated utility with stable cash flows, heavy transition capex, and rate recovery mechanisms. Nuclear-heavy generation portfolio provides competitive advantage. Execution risk on capex program and r...

FY2025 revenue +15% to .25B led by fitness (+33%), but deceleration vs FY2024. Margins stable. Auto OEM remains unprofitable. Strong cash generation. Taiwan concentration risk. Recommend HOLD—growth r...

CMG FY2025 10-K: Comparable sales declined 1.7% amid consumer weakness; transaction count down 2.9%. Company defending margins through pricing (+2.1%) and cost control despite food inflation (40bps) a...

Xcel Energy is a major regulated utility serving 3.9M electric and 2.2M gas customers across 8 states. Leading clean energy transition with 11,000 MW wind, 58% carbon reduction since 2005, and full co...

Ciena delivered exceptional FY2025 results (revenue +19% YoY to .8B) driven by unprecedented AI and cloud capex. Backlog surged to .0B (+138% YoY). However, gross margin compressed 80 bps to 42.0%, wi...

Quality Permian operator with strong 2025 execution; production +53%, margins held, capex controlled. Fair value $25-28/share assuming $55-60 WTI. Valuation full; limited upside at current levels. Rec...

Nasdaq 2025 10-K shows strong listing momentum, robust fintech growth, but faces SEC regulatory headwinds on trading rebates (Nov 2026) and execution risk on cloud transformation. Valuation pricing in...

Revenue +13.1% to $3.19B on AI semiconductor strength (+18.8%); Robotics down 15.5% post-restructuring. Gross margin stable 58.2%; inventory provisions elevated at $25.8M suggesting demand caution. AI...

EA Q3 FY2026: Revenue stalled (+1% YoY despite Battlefield 6), live services organic decline -3% 9M, gross margin compressed 200 bps. Merger at /share creating governance vacuum. Estimated Offering Pe...

FIX 2025 10-K: Revenue +29.5% to .1B, gross margin +310bps to 24.1%, operating income +75% to .3B. Backlog 99.3% up YoY to .9B. Tech sector driving growth (45% of revenue, data center capex). Executio...

Exelon FY2025: stable regulated earnings, strong liquidity, ~4x leverage, low single-digit EPS growth, multi-year capex visibility, ROE execution risk, fair value -54

Disciplined Permian consolidation: Badlands 100% ($1.8B) + Stakeholder ($1.25B) acquisitions. 11 Bcf/d gathering, 1.1 MBbl/d fractionation. $2.6B capex (8 processing plants, 3 fractionation trains, Sp...

Edwards delivered solid FY2025 with 11.5% revenue growth driven by TMTT (+56%) while TAVR matures (+9%). Strong balance sheet with $4.2B cash, $1.6B OCF. Key concerns: litigation expenses surged to $3...

Target reports Q3 2025 comp sales down 2.8%, driven by traffic decline (-1.9% YoY). Gross margin compressed 50 bps for 9M, offset partially by advertising growth. Operating margin down to 3.8% from 4....

ONEOK: Well-positioned integrated midstream platform with strong fee-based moat, recent strategic M&A (EnLink, Medallion) driving accretion, and disciplined capital allocation. Conservative valuation ...

OXY is a structurally advantaged large-cap integrated E&P with Permian dominance, superior CO2 EOR infrastructure, and rapid debt reduction post-OxyChem divestiture. 2025 saw volume growth offset by c...

ADSK executes channel transition flawlessly (direct sales now 66%) while maintaining subscription growth >110% NR3. Profitability solid (38% non-GAAP op margin), cash generation strong (.46B CF). Paya...

IDXX delivered 10% organic revenue growth in 2025 with 8.1% CAG Diagnostics recurring revenue growth. Operating margins expanded 90bps on comparable basis to 31.4%. Thesis: recurring diagnostics busin...

Keysight is a quality compounder expanding addressable market through software M&A while maintaining R&D discipline. Positioned in secular growth markets (AI, semiconductors, wireless) with durable mo...

Strong execution on share gains (70% of growth) and FMI platform but tariff pricing (170-200 bps) will fade in 2026. PMI <50 for 10/12 months signals weak macro. Gross margin compressed from customer ...

Market-leading rental company (15% share, .1B revenues) facing margin normalization after strong 2024. Net margin compressed 130 bps to 15.5%, primarily specialty segment pressure and used equipment m...

CARR completed portfolio transformation into pure-play climate/energy solutions in 2024. FY2025 showed revenue decline (-3%) with meaningful margin compression (operating margin 10% vs 11.8% YoY) desp...

Mature market position with near-term demand headwind. Same-Store revenue flat despite price power; cost inflation (property tax) and acquisition capex integration pressuring returns. Defensive divide...

Dominion is a well-positioned utility with strong regulatory support in Virginia and the Carolinas. Core assets (nuclear, transmission) provide stable cash flows; growth drivers include grid moderniza...

CAH reports strong Q2 (19% rev growth, margin expansion), driven by MSO platform acquisitions and pharma sales. However, rising leverage (B debt, 3.6x estimated net leverage), tariff headwinds, and MS...

CTVA 2025 10-K: Planned separation into Seed and Crop Protection. Seed strong with dominant Enlist E3; Crop Protection faces margin pressure from patents/generics. Regulatory (EPA), geopolitical (Chin...

Revenue up modestly on tariff headwinds & macro uncertainty, but margin compression and segment divergence (HTS stalling vs EA scaling) raised execution risk. UK exit is minor cost; real issue is whet...

AMETEK delivered record FY2025 sales (.4B, +6.6%), operating income, and EPS (.40, +7.9%) on organic growth (2%) + acquisition contribution (4%) + currency tailwind (1%). Strong backlog (.6B record) p...

MPWR 10-K restatement and material weakness in controls offset positive revenue diversification and AI/datacenter exposure. Execution risk elevated.

Allstate is the 3rd largest US P&C insurer, executing Transformative Growth strategy across personal lines (93.9% premiums). Key findings: (1) Underwriting margin pressure from inflation in vehicle re...

Ford 10-K shows volume decline amid unprofitable EV transition, elevated compliance costs (M/yr credits), deteriorating competitive position in China (1.3% share), and policy uncertainty creating stra...

NXP's 2025 revenue declined 2.7% YoY to .3B driven by Communication Infrastructure weakness (-23.6%) and Automotive stagnation (-0.5%), partially offset by Mobile growth (+5.8%). Gross margins compres...

Zoetis 2025 revenue .35B (U.S. 54%, Intl 45%). Patent cliff 2025-27 (Draxxin, Cerenia), dependent on lifecycle innovation fill. R&D up 2% to M. Companion animals 70% of revenue (resilient); livestock ...

AJG is 3rd largest insurance broker globally. Strong niche model (87% brokerage). Recent AssuredPartners acquisition creates integration risk. M&A track record strong but execution is key. Fair valuat...

VST is a B market cap integrated gen + retail player with 43.6k MW capacity, 5M retail customers. Recent Energy Harbor nuclear acquisition (4k MW) + 2025 nat gas bolt-ons transform portfolio. Fleet op...

Supplemental insurance pure-play with proven business model. Japan dominance creates earnings quality but FX risk. U.S. growth story intact but competitive landscape intensifying. Recent cybersecurity...

MPC 10-K: 2,787 mbpd crude throughput (+73 YoY), 3,718 mbpd refined product sales. Three-segment model with Refining (scale), Midstream (MPLX 64% hedge), Renewable (914M gal/yr). Total debt .3B, matur...

FTNT platform consolidation thesis remains intact post-FY2025. Strong margin expansion (27% net), global SASE leadership, and ASIC moat support continued outperformance. However, macro risks (geopolit...

Apollo offers asymmetric risk-reward as a diversified alternatives platform with embedded insurance cash flow. Secular headwinds offset by regulatory capital strength and capital allocation discipline...

Q1 delivered solid margin expansion (23.7%, +170 bps) on energy pass-through, pricing, and mix benefits. Restructuring charges ($28.3M) and $4B+ annual capex on NEOM/clean energy create execution risk...

DLR 2025 10-K reveals strong portfolio fundamentals (84.7% leased, 5K+ customers, 310 DCs globally) but highlights execution risks on power constraints, lease renewal, and customer concentration (top ...

PSX integrated downstream energy leader diversifying into renewables; strong midstream, exposed refining cycles and feedstock volatility. Capital-intensive growth projects ahead (CPChem 2027). LA refi...

AZO Q1 FY2026: Revenue +8.2%, SSS +4.7% but operating profit -6.8% on negative operating leverage. Gross margin compressed 200 bps (incl. M LIFO charge). ROIC deteriorated to 39.6% from 47.7% due to h...

O maintains fortress balance sheet, durable net-lease cash flows, global growth optionality, and dividend aristocrat status. Mature REIT; limited upside at current valuations given rate/macro uncertai...

Sempra 2025: Regulated utility stalwart undermined by bloated infrastructure portfolio. California utilities stable (SDG&E/SoCalGas 5-6% EPS growth), but SI Partners impairment cascade looming. SI inf...

Queue status: Unable to analyze without full filing details.

Valero faces structural headwinds: Benicia closure (-170K BPD), RFS Set II regulatory risk ('infeasible' compliance possible), California LCFS tightening (30% CI reduction by 2030), feedstock tariffs ...

Q1 FY26 shows mixed execution: solid segment growth in Connected Care and Interventional offset by tariff pressure and China softness. Waters spin complete. Litigation risks quantified but not show-st...

BKR thesis under pressure. IET growth (+10%) masks OFSE collapse (-8%). RPO backlog 92% concentrated in IET, signaling structural shift from traditional oilfield. Profitability declining despite cost ...

PCAR 10-K shows severe demand contraction and margin compression. Truck revenues down 22%, margins halved to 7.5%. Tariffs cost ~M. Market share losses in NA. PFS credit deteriorating (past dues up to...

ROST Q3 FY25 shows 7% comp growth and 10% sales growth, demonstrating strong value positioning in a pressured consumer environment. However, 45 bps operating margin compression from tariff costs and n...

EOG completed .7B Encino acquisition (Aug 2025) adding 675k Utica acres and 30% natural gas growth. FY2025 net income .0B (down 22% YoY) due to crude -15% price offset by gas +39%. Reserves +766 MMBoe...

TE Connectivity Q1 FY2026: Revenue +21.7% (15% organic), operating income +39.6%, margin up 260bps. Industrial Solutions growing 26% organically, led by AI/data center (+70%) and energy (+15% organic)...

L3Harris delivered 3% organic revenue growth with backlog acceleration to .7B (+13% YoY), signaling multi-year visibility. Margin resilience despite inflation, cost initiatives ramping (LHX NeXt). Key...

HOOD revenue growth strong at 51.6%, profitability achieved, but PFOF regulation risk (SEC rules mid-2026) and crypto uncertainty will pressure earnings. Diversification helps but PFOF still material....

TRV 2025 10-K review: Disciplined P&C franchise with strong domestic base, modest 2-3% organic growth, and strategic Canadian exit. Profitability hinges on rate increases staying ahead of inflation an...

WBD at inflection: Streaming profitability achieved but GLN structural decline accelerating. High leverage (3.2x), merger-induced operating constraints, and significant regulatory risk create valuatio...

ELV 10-K shows integrated health platform with defensive government revenue (32%) but facing 2026 headwinds: Medicaid redeterminations complete, enhanced PTCs expired 12/31/25. Star Ratings improvemen...

NSC 2025 10-K shows operational excellence (64.2% OR, +10% net income) but commodity cycles (coal -8% revenue, intermodal -1% units) and Union Pacific merger uncertainty create near-term headwinds. Fa...

RSG is a tier-1 waste management company with strong secular tailwinds, high barriers to entry, and credible circular economy positioning via Polymer Centers. Defensive growth profile supported by 22 ...

AON's 2025 10-K shows steady professional services growth with .2B consolidated revenue (.3B Risk Capital, .9B Human Capital). Strong competitive moat through scale, proprietary analytics, and recurri...

Regulated utility with strong moat. Growth supported by transmission capex cycle and renewable investment. Headwinds from coal retirement sequencing and regulatory uncertainty. Fair value ~-78 in bull...

Cencora delivered strong Q1 results with 5.5% revenue growth to .9B and impressive 20.1% gross profit expansion. The January 2025 RCA acquisition (B) is meaningfully accretive—gross margin expanded 46...

Capital-light franchise platform with strong unit growth but near-term margin pressure from labor inflation, owner leverage stress, and macro cyclicality. Requires full P&L analysis to establish convi...

CVNA at profitable scale inflection post-2023 recovery. Strong operational execution, secured market access for finance receivables. Margin expansion potential if AFR volumes/pricing sustain. Key risk...

GM's FY2025 shows core ICE strength offset by $7.9B restructuring (EV realignment + Cruise refocus) and China JV distress. Thesis: profitable legacy + EV optionality. Risk: if China turnaround fails o...

TDG revenue +13.9% YoY to 2.3B but EPS down 13.1% due to acquisition margin dilution (Gross margin 59.2% vs 61.6%) and rising interest expense. Net leverage 2.9x, heading toward 3.5x+ after 3.2B in an...

KMI is a stable infrastructure compounder with 85% fee-based revenues, 7-year contract visibility, and strong growth projects (Trident, Mississippi Crossing, SSE4). Fair value estimated at $43-49; cur...

DASH post-Deliveroo (Oct 2025 acquisition) faces near-term integration risk, Dasher cost inflation from EU worker reclassification precedent (Finland May 2025), and regulatory headwinds. Strong market...

SLB 2025 earnings show cyclical trough dynamics with encouraging stabilization signals. International activity declined 5% but Q4 inflection and Saudi recovery expected support 2026. Digital (28% marg...

SPG trades near fair value with execution intact but leverage + macro headwinds require tighter dividend monitoring. Rated HOLD pending Q1 guidance and refinancing visibility.

CI undergoes transformation divesting Medicare business while launching rebate-free PBM model. Regulatory headwinds (2028 PBM compensation reform) offset by operational scale in integrated benefits.

SNPS: Ansys integration proving dilutive; Design IP down 6%; gross margin collapsed from 81% to 74%; operating income DOWN despite 66% revenue growth; M restructuring in Q1 with -350M expected FY2026;...

ORLY FY2025: 6% sales growth, 4.7% comps (reacceleration), margin flat, EPS +10% on buybacks. Leverage rising (1.92x), DIY traffic declining, tariff pass-through driving pricing. Quality business, but...

CSX 2025: 3% revenue decline, 400bps margin compression to 32.1%, coal revenue -15%, good capex/free cash flow management, elevated labor costs. Quality Carriers continues to deteriorate. Intermodal b...

MDLZ is a diversified global snacking leader with strong moat, but faces near-term margin pressure from cocoa inflation, tariff exposure, emerging market volatility, and retail consolidation. Executio...

CL 2025 10-K reveals margin compression (-40 bps to -50 bps non-GAAP) from raw material cost inflation (+420 bps) overwhelming pricing gains and cost savings. Organic growth slowed to +1.4% on volume ...

FY2025: $11.7B revenue, $15.7B backlog (+7% YoY). Software & Services backlog $11.9B signals shift to recurring revenue model. Silvus ($4.4B acquisition) adds defense MANET but integration risk. Tarif...

CRH maintains strong infrastructure exposure with dominant market positions in aggregates, cement, and engineered products. 2025 marked by Eco Material acquisition, positioning company at forefront of...

CMI 2025 10-K reveals a company mid-transition. Accelera losses contained via impairment (hydrogen exit smart). Power Systems breakout (31% EBITDA on 18% sales) driven by data center power demand is t...

CTAS Q2: 9.3% revenue growth, 8.6% organic. Margin expansion led by uniform rental COGS efficiency. Aggressive capital return: M buybacks, M dividends. Valuation fair but not cheap at 43x P/E. Thesis ...

ABNB faces growth deceleration (guidance warnings), major regulatory/tax headwinds (IRS .3B dispute, EU/Spain/Italy restrictions), but maintains strong brand and profitable model. Tech stack refresh s...

Record 2024 results: B AUM, B deployed, B raised. Strong fundamentals with diversification benefits. Insurance integration validates long-term strategy. Valuation appears fair at current levels; upsid...

CDNS executes steady 14% organic revenue growth in core EDA with strategic IP and systems expansion through M&A. Settlement obligations (.6M) and China export uncertainty are near-term headwinds, but ...

REGN FY2025 10-K: Bifurcated portfolio — EYLEA biosimilar-driven structural decline (-17% YoY combined sales) partially offset by Dupixent growth (+26%). Margins pressured by high Sanofi profit-share ...

BK filed its 2025 10-K with stable but challenged fundamentals. A custody/payments/wealth management platform facing fee compression, margin headwinds from lower-for-longer rates, and competitive pres...

MNST energy drink franchise intact with strong international momentum, but Alcohol segment acquisitions (Bang, Monster Brewing) generating significant write-downs. TCCC distribution moat intact throug...

ITW delivers textbook operational execution: +130bps margin expansion from 80/20 process despite zero organic growth. Automotive OEM and Specialty outperform. NA geography weak. ROIC 29% but declining...

Quanta Services: Utility-scale infrastructure provider benefiting from grid modernization + data center capex. Strong market position (preferred provider, 70% utility customer base) offset by labor in...

Moody's is a market-leading integrated risk assessment firm benefiting from secular complexity growth, Gen AI positioning, and recurring revenue stability. Regulated both as CRA (MIS) and data/softwar...

EMR Q1 FY2026 shows strong underlying operations (+2% organic growth, pricing power, Test & Measurement surging +11%) but balance sheet severely leveraged from AspenTech acquisition, driving interest ...

RCL 10-K shows demand recovery intact with 9.4M passengers (2025) vs 8.6M (2024), 109.7% occupancy. Fleet disciplined with 12 ships on order through 2028. Key risks: regulatory (EU ETS, IMO CII), cape...

USB is a well-positioned B regional bank with .2B deposits, diversified income streams, solid capital position (SCB 2.6%), and growth opportunity via BTIG acquisition. Category III regulatory status m...

PNC positioned for FirstBank integration with ample capital and stable deposits. Key risks: CRE stress, NIM compression from falling rates, integration execution. Macro headwinds real but manageable g...

Solid execution on Next Gen rollout and client retention, but PEO Services margin compression and moderating employment growth are warning signs. Fair value appears $260-270 near-term, higher $280-300...

3M completed PFAS manufacturing exit at end of 2025. Adjusted EPS +10% YoY to $8.06 on margin expansion. Safety & Industrial leads (+3.9% / 24.9% margins). ~$16-18.5B in known PWS+CAE settlement cash ...

ECL delivered ~$16B in FY2025 revenue as a global leader in water, hygiene, and infection prevention. The data center water treatment vector is emerging as a material growth driver alongside biopharma...

JCI Q1 FY2026 delivers 7% revenue growth, 10% segment EBITA growth, and an extraordinary 39% surge in orders (+56% Americas) driven almost entirely by accelerating data center investments. Portfolio s...

STX Q2 FY2026 beat all metrics: revenue .825B (+21.5% YoY), gross margin 42% (+700bps YoY), net income M (+76% YoY). Nearline exabytes shipped +31% YoY to 165EB, fully validating AI-driven data center...

AMT's 10-K reveals a business in deliberate portfolio transition: shedding underperforming EM assets (India, Australia, NZ, South Africa), growing data centers to 10% of revenue, and dealing with two ...

SHW delivered record FY2025 revenue of .574B (+2.1% YoY) with gross margin expansion to 48.8%, but GAAP EPS declined 2.7% to .26 and adjusted EPS grew only 0.9% to .43. Paint Stores Group (+3.2% reven...

Marriott delivered solid FY2025 results — net fee revenues +5% to $5.3B, net income +10% to $2.6B — but US & Canada RevPAR grew only 0.7%, signaling meaningful weakness in business transient demand pa...

Williams FY2025 delivers record $7.75B Adj EBITDA (+~7% YoY), 2026 guidance $8.2B midpoint with 10%+ annual growth target through 2030. Key catalysts: Transco rate case settlement effective March 1 20...

Federal Express segment is structurally inflecting — 200bp margin expansion to 7.6% in Q2 as DRIVE cost savings flow through. FedEx Freight results are polluted by $248M in spin-off costs (H1); ex-sep...

Marsh completed its first full year post-McGriff acquisition (.75B deal, Nov 2024). Revenue reached ~B with 95,000+ colleagues across 130 countries. Risk & Insurance = 64% of revenue; Consulting = 36%...

NKE Q2 FY2026 (ended Nov 30, 2025): Revenue flat at .4B (+1% reported, 0% currency-neutral). Gross margin compressed 300bps to 40.6%, primarily driven by ~.5B annualized tariff impact in North America...

ICE delivered record .9B in net revenues (+6% YoY) and GAAP diluted EPS of $5.77 (+21%). Three-segment model showing healthy diversification: Exchanges $5.4B (55%), FIDS $2.4B (24%), Mortgage Tech $2....

Sandisk (spun off from WDC Feb 2025) delivered a blowout Q2 FY2026: revenue +61% YoY to .0B, gross margin expanded 1,900 bps to 50.9%, operating income .07B (35.2% margin), net income M. In H1, the co...

ARR grew to $4.92B (+23% YoY) with Q3 net new ARR of $265M — the strongest quarter since before the July 19 Incident — validating thesis recovery. Revenue $1.234B (+22%), subscription gross margin 78%...

Post-Sandisk-separation WDC is firing on all cylinders: 25% revenue growth, 800bps gross margin expansion to 45.7%, .25B H1 FCF. Cloud/AI demand driving everything. Key risk: .6B convertible notes at ...

EQIX FY2025: Revenue .217B (+5% as-reported, +6% normalized/CC). Adjusted EBITDA .53B, 49% margin. AFFO .33/share (+9% YoY). Q4 gross bookings M annualized (+42% YoY) — the clearest AI demand signal y...

GD delivers a clean FY2025: revenue +10.1% to $52.6B, EPS +13.4% to $15.45, FCF $4B. The headline is the backlog: total jumped 30% to $118B ($179B TCV), driven by $20.1B in submarine awards. Aerospace...

WM FY2025 10-K review. Revenue .2B (+14.2% YoY, Stericycle-driven). Op EBITDA grew 13.3% to ~.7B. Core business execution solid but two headwinds: (1) Stericycle ERP/billing issues causing revenue mis...

FCX's 2025 was defined by the September mud rush at Grasberg (7 fatalities, halted Grasberg Block Cave operations), which devastated production in H2 2025. Despite this, copper prices averaged .51/lb ...

Revenue -2.6% to $88.7B driven by deliberate Amazon volume reduction, Coyote divestiture, and Mail Innovations decline. Operating margin compressed 40bps to 8.9% but $3.5B in cost savings delivered. H...

DELL Q3 FY2026: Revenue +11% YoY to B. ISG +24% driven by AI servers (+37% YoY). Product gross margin compressed 130bps to 14% from AI server mix shift. Operating income +23% to .1B. Non-GAAP EPS .59 ...

CVS posted record B in 2025 revenue (+7.8%) and adjusted OI of .4B (+20.6%), but GAAP operating income collapsed 45% to .7B after a $5.7B goodwill impairment on Health Care Delivery (Oak Street/Signif...

DUK delivered 2025 adj. EPS of $6.31 (+6.9% YoY), announced the largest capex plan in US utility history at $103B (2026-2030), and extended 5-7% EPS CAGR target through 2030. Data centers = 75% of eco...

TT delivered exceptional FY2025 results: revenue +7.5% to .3B (organic +6.2%), operating margin expanded 100bps to 18.6%, free cash flow .89B, backlog surged 15% to .77B. Americas commercial HVAC led ...

NOC FY2025: Revenue +2% to .95B (organic +3%), segment margins compressed to 10.4% from 11.1% due to B-21 Q1 loss provision. Backlog surged to $95.7B. B-21 LRIP losses STABLE in Q4 2025 — the key infl...

HWM delivered a spectacular FY2025: .25B revenue (+11%), net income .51B (+31%), Adj. EBITDA .51B (+25%). COGS margin improved 310bps in one year. Operating cash flow surged 45% to .88B. All four segm...

SO delivered adjusted EPS of $4.30 in 2025 (top of guidance for 11th straight year). The real story: data center-driven commercial sales +17% for 2nd consecutive year, 26 signed contracts for 10 GW of...

FY2025 revenue +11% to .77B, net income +28% to .13B, FCF .03B (+25%). Total Adobe ARR .20B (+11.5%). Stock at 52-week lows near 10x forward earnings. AI platform (Firefly, Acrobat AI Assistant, GenSt...

Q1 FY2026 shows real comp momentum (+4% global, +4% US, +5% International) but severe margin compression (-290bps to 9.0% operating margin). North America margins collapsed -480bps to 11.9% from Nicco...

Comcast FY2025: Revenue flat at $123.7B, Adj EBITDA -1.8% to $37.4B. Broadband sub losses accelerated (-711K vs -411K in 2024). Wireless growing +1.5M lines. Versant spun off Jan 2026. Hulu sold for $...

Q2 FY26: revenue +17% YoY to .65B; H1 operating income +61% on 18% revenue growth — extraordinary scale leverage. QBO Accounting +24%, Credit Karma +25% (loan/card/insurance recovery), QuickBooks Capi...

FY2025: Revenue .3B (+21% YoY), FCF .6B (+34%, 35% margin), Non-GAAP OpInc .1B (+27%). RPO .2B (+27%), cRPO +25% — 2+ years of forward visibility. 98% renewal rate. 603 customers >M ACV (+20%). Stock ...

Boston Scientific delivered exceptional FY2025 results — .1B revenue (+19.9% reported, +15.8% organic), driven overwhelmingly by FARAPULSE PFA System dominating the atrial fibrillation EP market. Adju...

CME posted record FY2025 results: .51B revenue (+6.5%), net income .1B, adj. EPS .20 (+15.4%), record ADV of 28.1M contracts (+6%). Business model continues to compound on scale and regulatory tailwin...

MO delivered 4.4% adjusted EPS growth (.19→.42) but fell short of its mid-single digit CAGR goal (3.6% 3yr CAGR). NJOY ACE banned from US market via ITC patent ruling, triggering ~.9B impairment. Ciga...

HCA posted strong FY2025 revenue of $75.6B (+7.1% YoY), driven by 2.7% admission growth and surging Medicaid supplemental payments ($6.2B vs $4.4B in 2023). However, the Federal Budget Act creates a m...

CEG's FY2025 10-K reveals best-in-class nuclear operations (94.7% capacity factor, 4% above industry average) with structural IRA PTC support providing a margin floor. Adjusted EPS of $9.39 landed in ...

IBKR delivered exceptional FY2025 results: revenue +20% to $6.2B, net income +28% to $4.4B, pretax margins ~75%. Added 1M+ accounts to >4M total; client equity approaching $780B. Operating leverage is...

Q2 FY2026 shows 15% revenue growth to $2.6B, operating margin expanding 470bps YoY to 15.3%, NGS ARR of $6.3B, and FCF of $2.1B H1. Chronosphere acquisition closed Jan 29 for $3B; CyberArk closed post...

Revenue +15% YTD to B; diluted EPS +57% YTD to .73. North American Pharma (+13% rev, +39% op profit) and Oncology & Multispecialty (+30% rev, +54% op profit) carrying the story. Two major oncology acq...

Capital One closed the Discover acquisition on May 18, 2025 for .8B, becoming the largest US credit card issuer and acquiring the Discover Network, PULSE, and Diners Club. COF also announced Brex acqu...

Progressive delivered best-in-class underwriting in Q3 2025 despite a M one-time Florida policyholder credit that obscures the true earnings power. Ex-credit, Q3 combined ratio was ~85% — elite. Net p...

Q3 beat on revenue (+9% YoY to .0B) driven by Cardiovascular (+14%) and Diabetes (+15%), but GAAP EPS declined to /bin/zsh.89 vs .01 as restructuring ballooned (M) and litigation charges hit (M). Non-...

VRTX delivered .0B in FY2025 revenue (+9% YoY), net income .0B (.32 EPS), 86.2% gross margin, 34.8% operating margin, .1B cash, zero long-term debt. CF franchise (~75% patient penetration) remains the...

BMY at a structural inflection: 2026 is the trough year as Eliquis goes to Medicaid-free + IRA MFP (Medicare), Revlimid hits full generic competition Jan 31 2026. Revenue was flat FY2025 at .2B vs .3B...

Parker-Hannifin posted solid Q2 FY2026 results with 9.1% revenue growth and meaningful margin expansion in both segments. The real story is twofold: (1) the Aerospace Systems segment is on fire — 14.5...

FY2025 was a breakout year for GLW. Core net sales +13% to $16.4B, core EPS +29% to $2.52, and the 20% core operating margin target hit a full year early. Optical Communications (+35% revenue, +71% ne...

Revenue grew 6% YoY to .7B (5% LC). Adjusted operating margin expanded 30bps to 17.0% ex-M restructuring charges (now complete). Book-to-bill ~1.12x on .9B new bookings (+12%). Managed services accele...

PLD delivered Core FFO of $5.81/share (+4.5% YoY) in FY2025, with 95% average occupancy and record 228M sq ft of leasing. An 18% remaining rent mark-to-market ensures durable organic growth for years....

FY2025 revenue .3B with strong Ratings and Indices growth; GAAP EPS .66; 2026 adj EPS guided .40-19.65 (~33% growth); Mobility spin-off planned mid-2026 as major catalyst; current price represents ~2...

Chubb delivered record results across virtually every metric in FY2025. Core operating income of $9.95B (+8.9%), NPW of $54.8B (+6.6%), and a record-low P&C combined ratio of 85.7% — achieved despite ...

Revenue +13.4% to .9B, room nights +8% to 1.24B, gross bookings +12.4% to B. Transformation Program delivering >M in run-rate savings. Merchant mix shift to 70% (from 63%) accelerating. Key red flag: ...

COP delivered 2,375 MBOED production (+20% YoY) driven by Marathon Oil acquisition. CFO of $19.8B, FCF $7.2B, returned $9.0B (46% of CFO) to shareholders. Marathon synergies hit $1B run-rate, $5B asse...

Blackstone's 2025 10-K confirms the firm's structural growth thesis is intact despite near-term headwinds. AUM grew to .3T+ across four segments: Credit & Insurance (B), Private Equity (.4B), Real Est...

Newmont delivered a blockbuster FY2025 on the back of gold at ,498/oz avg and a leaner portfolio post-divestitures. Revenue surged to .7B (+21% YoY), net income hit .2B, FCF reached .3B. The company s...

Welltower delivered an exceptional FY2025: normalized FFO/share of $5.29 (+22.5% YoY), total portfolio SSNOI growth of 15.0% (Q4) with SHO SSNOI of 20.4% Q4 and 21.5% FY. Revenue up ~36% including maj...

ETN delivered 10.3% revenue growth to $27.4B in FY2025, accelerating from 7.3% in 2024. Electrical Americas Systems revenue surged 19.5% to $10.1B — nearly tripling from $7.1B in 2023 — confirming the...

AppLovin delivered exceptional FY2025 results: revenue +70% to .48B, net income +111% to .33B, Adjusted EBITDA +87% to .51B at 82% margins. Pure software economics (89% gross margin) driven by Axon AI...

Stryker delivered 11.2% revenue growth to $25.1B in FY2025. Organic constant-currency growth of ~9.9% demonstrates durable competitive positioning. MedSurg/Neuro grew 15.7% (Inari acquisition drove Va...

LOW delivered 3.2% revenue growth and 50 bps gross margin expansion in Q3 FY25, but GAAP EPS declined YoY due to M in acquisition-related costs. The .8B FBM acquisition (closed Oct 9, 2025) — combined...

Danaher delivered modest FY2025 recovery: .6B revenue (+3.0%), adj. EPS .80 (+4.5%), FCF .3B. Bioprocessing strengthening but Life Sciences segment profit collapsed 57%. Pending Masimo acquisition add...

Revenue +5% YoY to .25B but net income -6% to .0B as cost inflation bites. QCT automotive +15% and IoT +9% diversification real but insufficient to offset impending Apple modem share loss. Alphawave a...

FY2025 sales +6% to B; record B backlog (2.6x sales, BTB 1.2); segment OP +11% to .7B but hit by .6B program charges (classified Aero + CMHP + TUHP); FCF .9B beat; 2026 guidance: -80B sales, segment O...

Uber delivered a third consecutive year of 20%+ gross bookings growth in FY2025: GBs .5B (+19% YoY), revenue .0B (+18%), Adj. EBITDA .7B (+35%). FCF inflecting strongly. The platform network effect an...

PFE FY2025: ~.2B revenue (down ~2.5% from ~.8B in 2024). International .5B = 41% of total. COVID product normalization masks ex-COVID stability. Massive patent cliff ahead: Eliquis (2028), Ibrance (20...

UNP delivered best-ever FY2025 results: OR improved to 59.8%, EPS +8% to .98, freight revenues +2% to .2B. Operational metrics at all-time highs (freight car velocity +8%, dwell -8%). Coal surge (+20%...

Honeywell delivered 8% revenue growth to .4B in FY2025, led by Aerospace Technologies (+13%, 3rd consecutive year of double-digit growth). The defining story is the planned HON/Aerospace separation (Q...

BlackRock's FY2025 10-K reveals a firm in strategic transformation — from dominant asset manager into an integrated financial infrastructure platform. AUM crossed T (+21% YoY), as-adjusted EPS grew to...

ANET delivered 28.6% revenue growth in FY2025 (~.0B), operating margins hit a 'historic milestone' of 47.5%, and Q4 EPS of $0.82 beat consensus by $0.07. Q1 2026 guidance of ~$2.60B implies continued ...

Q1 FY2026 (period ended Feb 1, 2026): Revenue +13% YoY to $9.6B driven by higher volumes and FX tailwinds, but net income fell 24% to $656M ($2.42 diluted) as $361M pretax tariff impact crushed margin...

Charles Schwab delivered record FY2025 results: revenue of $23.9B (+22% YoY), Q4 net income $2.5B ($1.33 EPS). The defining thesis is the full reversal of the 2022-2023 cash sorting headwind. With $11...

Exceptional Q1: revenue +30% YoY to $3.16B, gross margin +570 bps to 64.7%, net income doubled to $831M. Communications +63% on AI/datacenter wireline. Industrial +38%. Automotive +8% (soft). $1.37B O...

Boeing delivered a surface-level turnaround in FY2025 with revenue of $89.5B (+34.5% YoY) and net income of $2.2B vs an $11.8B loss in 2024. However, 60-70% of the apparent profitability came from a o...

FY2025: .1B revenue (+20.5% YoY, 5Y CAGR 18.2%), EBITDA .6B (+27%), FCF .5B (+91%), gross margin 66.0%, operating margin 29.3%. dV5 now 57% of Q4 system placements — a genuine platform transition. Key...

Amphenol delivered exceptional FY2025 results — revenue +52% to $23.1B (+38% organic) — driven by AI infrastructure demand (IT datacom = 36% of sales, +~$4.6B YoY). Backlog surged 46% to $8.9B, valida...

TJX reported exceptional Q3 FY2026 results: +7% revenue growth, +5% comp, 12.7% pre-tax margin (+40bps YoY), and EPS of $1.28 (+12.3%). All four segments grew. Merchandise margin expanded sharply on l...

FY2025 total revenues .4B (+2%). Core HIV franchise delivered with Biktarvy .3B (+7%), Descovy .8B (+31%). Yeztugo (lenacapavir PrEP) launched — first 2x/year HIV prevention therapy. Cell therapy decl...

Q3 FY26 solid at 9% revenue growth / 21% op margin. Agentforce 360 Platform surging +19% YoY — the AI monetization thesis is live. Informatica (.6B acquisition, closed Nov 2025, funded with B floating...

Q1 FY2026 revenue grew 5% to .0B but net income fell 6% to .4B. The headline miss is driven by a 35% collapse in Entertainment operating income (theatrical cost ramp) and a one-time M non-cash Fubo ta...

Revenue recovered to .68B (+13% YoY), roughly matching 2023 peak. Gross margins compressed to 57% from near-63% at peak as 300mm capex cycle weighs. The critical 2026 story is CapEx dropping from .55B...

NEE delivered a strong FY2025 with ~80GW capacity, FPL securing a landmark rate agreement (+$1.65B annualized revenue by 2027, 10.95% authorized ROE), and NEER adding 1,604MW wind, 2,859MW solar, 1,79...

TMO delivered .6B in FY2025 revenue (+4%, +2% organic), adjusted EPS .87 (+5%), adjusted operating margin 22.7%. Life Sciences Solutions led growth driven by bioproduction recovery and Solventum filtr...

Citi's 2025 10-K confirms transformation thesis: revenue +7% adj, net income .1B adj, CET1 13.2%. Banamex exit complete, Russia charges taken. Forward P/E 9.1x on + EPS implies massive re-rating poten...

AT&T posted solid FY2025 results driven by fiber subscriber momentum (+1.1M net adds to 10.4M), FWA acceleration (+875K to 1.5M), and portfolio simplification via DIRECTV sale. Revenue grew 2.7% to $1...

Revenue +7% YoY to .30B in Q2 FY26; H1 +10% to .51B. Gross margin expanded 110bps YoY to 61.4%. Net income .15B in Q2, .27B in H1. Operating CF .53B in H1 — exceptional FCF engine. Patterning +31% YoY...

Abbott delivered solid FY2025 results led by CGM dominance (.6B, +17%) and MedDevices segment growth (+12%), with expanding operating margins (16.3%→18.2%). The transformative pending acquisition of E...

Product sales .1B (+9.7% YoY) driven by Horizon integration. Core headwinds: Prolia/XGEVA patent expiry (Feb/Nov 2025), ENBREL IRA pricing kicking in Jan 2026, Otezla IRA 2027. Bull catalysts: MariTid...

VZ reported solid FY2025 results (revenue +2.5% to $138.2B) driven by Consumer (+3.8%) offsetting Business decline (-1.6%). Frontier acquisition closed Jan 20 2026, expanding fiber to 31 states — tran...

AXP delivered record FY2025 revenue of $72B (+10% YoY), EPS $15.38 (+15% ex-gains), ROE 34%. Net card fees hit $10B (+18%), billed business +8% FX-adj. Credit quality remains exceptional — delinquenci...

IBM delivered a strong FY2025 with .5B revenue (+7.6% YoY), record free cash flow of .7B (+B YoY), and Q4 net income surging 93% to .6B. Software (+11%) and Infrastructure (+12%, z17 mainframe cycle) ...

Intel FY2025: revenue .9B (flat), gross margin 34.8% (improving), operating loss narrowed to -.2B from -.7B. Intel 18A entered high-volume production, NVIDIA paid B for strategic stake at $23.28/share...

FY2025 revenue +2.2% to $93.9B (M&A-aided), but operating profit fell 10.9% to $11.5B vs $12.9B in 2024. North America is the problem child — 15% price cuts on Lay's/Doritos/Cheetos signal volume pain...

LIN delivered another year of pricing-driven margin expansion — adjusted op margin 29.8%, adj EBITDA 39.3% — but volumes were flat as European industrials slumped and APAC China softened. Revenue +3% ...

FY2025 revenue .1B (+9%), orders .3B (+34%), total backlog B (+B YoY). Adj EBITDA margin 8.4% (+210bps). FCF .7B (+118%). Power and Electrification driving thesis; Wind remains drag. 2026 guidance rai...

TMUS delivered industry-best results in FY2025: service revenue +8% to $71.3B, Core Adjusted EBITDA +7% to $33.9B, FCF $18.0B. Postpaid phone net adds of 3.3M and total net adds of 7.8M were industry-...

McDonald's delivered a solid 2025 rebound — global comps +3.1% after flat/negative 2024 — with all segments positive. Revenues +4% to $26.9B, operating margin expanded to 46.1%, FCF $7.2B. Key concern...

WFC's FY2025 10-K + Q4 earnings reveal a company at an inflection point. The Fed asset cap was removed June 2025, enabling 11% asset growth. Full-year net income hit $21.3B (+17% EPS), ROTCE rose to 1...

GS delivered record FY2025 results: .28B revenues, .18B net income, .32 EPS, 15.0% ROE. The costly consumer pivot is now complete (Apple Card, GreenSky, Marcus all exited). Core GBM + AWM franchise is...

MS delivered a breakout FY2025: revenues +14% to .6B, EPS .21, ROTCE 21.6%. Wealth Management hit record .75B (NNA of B), Institutional Securities hit record .1B. Capital position strong (CET1 15%), B...

UNH's Q3 2025 filing reveals the worst earnings reset in the company's modern history. MCR hit 89.9% in Q3 (+470bps YoY), earnings from operations collapsed 50% to .3B, and EPS fell to .59 from .51. T...

RTX delivered a strong FY2025: .6B revenue (+10%), adj. EPS .29 (+10%), FCF .9B (+75%). Backlog surged to B from B (+23% YoY). P&W GTF headwind peaking; international defense the growth engine. Legal/...

PMI delivered .6B net revenues (+7.3%, +6.5% ex-currency/A&D) in FY2025. Smoke-free product volumes grew 12.8% to 179.1B EUs, now 22.8% of total mix. GAAP diluted EPS of .26 (+60.6% vs 2024), heavily ...

Blowout quarter: revenue +22% YoY to .34B, gross margins hitting 50%, net income +34% YoY. Foundry now 59% of mix (from 35% YoY) — directly maps to TSMC/Samsung AI node buildout. China at 35% of Q2 re...

Revenue -2% YoY (.01B), but the mix is improving: Taiwan +46% on TSMC N2 ramp, DRAM share expanding (34% vs 27%), AGS +15%. The M BIS settlement removes key legal overhang. Gross margin held at 49% de...

FY2025 total sales B (+1.3% YoY). Keytruda/Keytruda Qlex grew 7.4% to .7B but Gardasil collapsed 39% to .2B on China market headwinds. Winrevair (PAH) exploded 244% to .4B — the next growth engine. Ca...

Cisco delivered a clean beat in Q2 FY2026: revenue +10% YoY to $15.35B (vs $15.12B est), adj EPS $1.04 (vs $0.94 est, +10.6% beat). Networking product revenue surged 21% driven by AI Infrastructure so...

AMD delivered 34% revenue growth to .6B in FY2025 — a genuine AI infrastructure inflection. Data Center +32% to .6B, Client/Gaming +51% to .6B. Landmark OpenAI deal (6 GW GPU commitment) validates hyp...

PLTR delivered .5B in FY2025 revenue (~57% YoY growth if FY24 was ~.87B), with 954 customers, .2B remaining deal value, and top-20 customer spend jumping 45% YoY (.6M → .9M avg). AIP bootcamps driving...

FY2025 revenue +4% YoY to $67.6B but EPS fell 15% ($22.05→$18.81) as operating margin contracted 370bps to 16.5%. The story is the backlog: $51.2B at Dec 31, 2025 vs $30.0B a year prior (+70.7%), larg...

Coca-Cola's FY2025 10-K reveals a business that is fundamentally sound but showing early strain. Net revenues grew 2% reported (.9B) and 5% organically, but unit case volume was flat for the full year...

GE Aerospace delivered a breakout FY2025: revenue +18% to .9B, adj EPS +38% to $6.37, FCF +24% to $7.7B. CES margin expanded to 26.6%. The LEAP engine fleet is entering its prime MRO window — internal...

BAC FY2025 10-K reveals a bank that has successfully navigated the rate cycle: NII hit its bottom and reversed, credit quality is improving, and the capital return engine is firing. Net income .5B (+1...

CVX FY2025 was a year of transformative scale-up. The Hess acquisition closed in July 2025, adding the Bakken, Gulf of America assets, and critically a 30% stake in Guyana's Stabroek Block — one of th...

HD's core retail business is treading water (+0.2% comps Q3, +0.3% YTD) while management bets big on Pro distribution via SRS (B, Jun-24) and GMS (.1B, Sep-25). Revenue growth is acquisition-fueled, n...

PG's Q2 FY2026 shows a franchise under real cost pressure. Organic growth stalled at 0% in Q2 (1% H1), gross margin compressed 90-120bps driven by tariffs and mix, and Core EPS grew only 2%. Volume is...

Netflix delivered a clean FY2025 with 16% revenue growth, 29.5% operating margin (+280bps), and .15B operating cash flow — all ahead of internal targets. The filing is dominated by the Dec 4, 2025 WBD...

AbbVie's FY2025 10-K confirms the Humira biosimilar cliff is now a tailwind story, not a headwind. Skyrizi+Rinvoq = 42% of total revenue and growing. Forward P/E 14.4x on .12 EPS is attractive for a f...

Oracle's Q2 FY2026 filing reveals a company in the middle of a historic cloud transformation. OCI (cloud infrastructure) grew 68% YoY to .1B in the quarter, becoming Oracle's largest revenue segment. ...

Costco delivered a strong Q1 FY2026: net sales +8%, membership fees +14%, EPS +11.4%, and operating cash flow surged 44% YoY to $4.69B. The business is firing on all cylinders — but at 45x forward P/E...

MA delivered 16% revenue and net income growth in FY2025 with .8B revenue and .0B net income. GDV of $10.6T grew 15% (local currency). Exceptional cash generation ($14.5B from ops), aggressive capital...

Blowout quarter — revenue +57% YoY to $13.6B, gross margins exploding to 56% from 38% a year ago, net income $5.24B. CMBU (cloud/HBM) segment doubled YoY. Rapid debt paydown, $12B cash pile. YMTC liti...

JNJ delivered solid FY2025: $94.2B revenue (+6.0% reported, +4.2% adj. operational), adj. EPS $10.79. DARZALEX (~15% of revenue) is the engine. STELARA biosimilar erosion is live and accelerating. Int...

Visa delivered a clean 15% revenue growth quarter with non-GAAP EPS of $3.17 (+15% YoY). Value-added services accelerated to 32% growth ($3.2B). The $708M litigation provision is covered by the retros...

XOM FY2025 delivers record production (+9.3% YoY to 4,736 Mboe/d) on Pioneer integration, but earnings fell for 3rd straight year (.8B net income vs .7B in 2024) as realized crude prices dropped from ...

Record .5B net income, B revenue, 20% ROTCE. Apple Card acquisition creates near-term capital drag but is strategically sound. All four segments performing. 2026 NII guidance B. Valuation reasonable a...

LLY 10-K for FY2025 confirms blockbuster GLP-1 trajectory. Q4 2025 revenue of .29B (+43% YoY) crushed .96B consensus. Mounjaro/Zepbound account for 56% of total 2025 revenues. 2026 guidance of -83B im...

Walmart Q3 FY2026 (Oct 31, 2025): Net sales .8B (+5.8% YoY), comp sales +4.8% Walmart US. E-commerce contributing ~4.4% of 4.8% comp — digital flywheel is real. Operating margin compressed 22 bps to 3...

BRK Q3 2025 10-Q reveals a company running a near-record B cash/T-bill pile with zero buybacks, a major KHC impairment thesis break, OxyChem acquisition announced post-quarter, strong GEICO/BNSF opera...

FY2025 revenues fell 3% to $94.83B as vehicle deliveries declined to 1.64M. GAAP net income collapsed 46% to $3.79B ($1.08 EPS) while gross margins improved to ~20.1%. Cash surged to $44.06B; debt min...

AVGO is firing on all cylinders: FY2025 revenue +24% to .9B, AI semi revenue growing 74% YoY in Q4, VMware software converting to high-margin subscriptions. The B AI backlog provides exceptional visib...

META delivered exceptional FY2025 with .97B revenue (+22% YoY) and 41.4% operating margin. Core ad business is re-accelerating (Q1 2026 guidance implies 25-30% growth). However: FCF compressed from $5...

AWS re-accelerated to 20% growth at $128.7B revenue with $45.6B OP income (35.4% margin, slight compression from capex). Total revenue +12% to $716.9B. FCF collapsed from $38.2B to $11.2B as capex sur...

Azure reaccelerated to 39%, commercial RPO surged 110% to $625B, and operating margin expanded to 47%. GAAP EPS was massively inflated by a $10B OpenAI dilution gain. Adjusted EPS +24%. CapEx intensit...

GOOGL's FY2025 10-K shows a company in transition: Search remains dominant (+13% YoY) while Cloud is the real story (36% growth, operating income doubling to .9B). The bear case is structural: .4B Cap...

Record Q1: .8B revenue (+16%), .1B net income (+16%), 48.2% gross margin (+130bps). iPhone +23% driven by Pro mix. Greater China +38% (massive reversal). Services +14% at 76.5% gross margin. R&D +32% ...